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Abbreviations 
 
 
aa    Amino acid 
Å    Ångström 
AMP    Adenosine mono phosphate 
AP    Alkaline phosphatise 
APS    Ammonium persulphate 
Bis-Tris   Bis(2-hydroxyethyl)amino-tris(hydroxymethyl)methan 
CDP    Cytosine diphosphate 
CV    Column volume 
kDa    Kilo Dalton 
E. coli    Escherichia coli 
DMSO    Dimethyl sulfoxide 
DOT    Defect in orgnalle trafficking 
EDTA    Ethylenediaminetetraacetic acid 
ER    Endopalsmic reticulum 
GAP    GTPase activating protein 
GDP    Guanosine di phosphate 
GTP    Guanosine tri phosphate 
GEF    Gaunosine nucleotide exchange factor 
GDI    Guanosine nucleotide dissociation Inhibitor 
GDF    GDI displacement factor 
GGTase   Geranylgeranyltransferase 
LCV    Legionella containing vacuole 
ICM    Intracellular multiplication 
ITC    Isothermal titration calorimetry 
IEC    Ion exchange chromatography 
IMAC    Immobilized metal ion affinity chromatography 
IPTG    Isopropyl-β-D-thiolgalactoside 
KPi    KH2PO4/K2HPO4 
MWCO   Molecular weight cut off 
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Mg2+    Magnesium ions 
Ni-NTA   Nickel-nitrilotriacetic acid-agarose 
NMR    Nuclear magnetic resonance 
OD600    Optical density at 600 nm 
PAGE    Polyacrylamid gel electrophoresis 
PCR    Polymerase chain reaction 
PDB    Protein data bank 
Pi    Inorganic phosphate 
PI(4)P    Phosphatidylinositol 4-phosphatase 
Rab    Ras-related proteins in brain 
REP    Rab escort protein 
SDS    Sodium dodecyl sulphate 
SEC    Size exclusion chromatography 
SNARE   Soluble N-ethylmaleimide-sensitive factor attachement 
protein receptor 
SPR    Surface plasma resonance 
TAE    Tris-acetate-EDTA 
TBS    Tris buffered saline 
TCA    Trichloroacetic acid 
TEMED   N, N, N’, N’ – Tetramethylendiamin 
Tris    Tris (hydroxymethyl) aminomethane 
T4ASS   Type 4 A secretion system 
T4BSS    Type 4 B secretion system 
UTI    Urinary tract infection 
WHO    World Health Organization 
wt    Wild type 
 
 
Amino acids are abbreviated using 1 or 3 letter code. 
Latinisms are written in italic. 
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Summary 
 
Rab1 is a small GTPase that regulates intracellular trafficking between the 
endocytoplasmic reticulum (ER) and the Golgi complex. In common with other GTPases, 
cytosolic Rab1 is normally kept in a GDP-bound, inactive state by a dedicated GDP-
dissociation inhibitor (GDI). To activate Rab1, a GDI-displacement factor (GDF) is 
required to remove the GDI before a GTP exchange factor (GEF) can induce the release of 
GDP to allow for subsequent uptake of GTP and activation of Rab1. SidM is a type IV 
secretion system effector protein from Legionella pneumophila that has both GEF and 
GDF activity for Rab1GTPase. SidM recruits Rab1 to the Legionella-containing vacuole 
(LCV) as part of generating a specialized vacuole that resembles the host’s rough 
endoplasmic reticulum. Within this vacuole L. pneumophila creates a replication niche 
allowing it to evade destruction by lysosomal fusion. To understand the SidM/Rab1 
complex at the atomic level, the central domain of SidM317-545 and Rab1A1-175 were each 
purified and co-crystallized. Complex formation of SidM/Rab1 was analysed by size 
exclusion chromatography and isothermal calorimetry. The structure of the SidM/Rab1A 
complex was determined by X-ray crystallography revealing that the GEF domain of SidM 
is structurally distinct from known eukaryotic GEFs. The structure of the complex further 
revealed that SidM induces several conformational changes in Rab1A to facilitate GDP 
release. ITC experiments show that SidM has a higher affinity for unbound Rab1A 
compared to GDP-bound Rab1. 
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1 Introduction 
 
Infectious diseases pose a significant threat to the global population. Recent reports from 
World Health Organization (WHO) have shown that infectious diseases account for more 
than 17 million deaths every year, the majority of which are due to bacterial infections 
(Millar et al., 2007). Bacterial infections result in acute to chronic illnesses especially in 
elderly people, children and immunocompromised patients. Common bacterial infections 
include pneumonia, diarrhea, urinary tract infections, ear and skin infections. Despite the 
availability of broad range of antibiotics, new bacterial strains are emerged that develop 
resistant to antibiotics. According to the latest reports from WHO, antibiotic resistant 
bacterial infections annually result in ~ 25 thousand deaths in the European Union alone 
(Reports from European Center For Disease Prevention And Control (ECDC, 2012). The 
associated medical costs and lost productivity are estimated to be around € 1.5 billion per 
year (Reports from European Center For Disease Prevention And Control (ECDC, 2012).  
Pathogenic bacteria have developed numerous strategies to escape the host immune system 
and survive inside host cells. Understanding the molecular mechanisms involving host-
pathogen interactions is essential for the development of novel antimicrobial drugs and 
vaccines. In recent years, structural biology has become a powerful tool in the field of 
modern drug discovery. Use of structural biology methods such as X-ray crystallography 
and NMR will allow us to solve the three dimensional structures of biological proteins. 
This information can be used to design the therapeutic agents against the target proteins 
involved in the infectious diseases.  
 
1.1 Legionella pneumophila 
 
The genus Legionella is a Gram negative, aerobic, rod shaped motile bacterium that belong 
to the family of Legionellaceae (Edelstein 2007). To date more than 50 species of 
Legionella have been identified. Among them, Legionella pneumophila is a pathogenic 
bacterium that is universally found in freshwater environments such as ponds, lakes and 
also in association with amoeba and man-made aquatic environments like swimming 
pools, air-conditioning systems, cooling towers, water tanks, refrigerators, showers, 
respiratory devices etc. 
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In humans, L. pneumophila causes two forms of infections: Legionnaires’ disease and 
Pontiac fever. Legionnaires’ disease is a severe form of a pneumonia characterized by high 
fever, body pains, headache, nausea, shortness of breath and respiratory disorders that 
leads to chronic lung disease and can cause death in 5 to 30 % of the infected individuals 
(Edelstein 2007); (Tronel and Hartemann 2009; Cunha and Syed 2010) Legionnaires’ 
disease was named after a massive outbreak of pneumonia affecting veterans at the 
American Legion convention in Philadelphia in 1976. Legionnaires’ disease most 
commonly occurs in individuals suffering from chronic lung diseases, diabetes, 
AIDS/HIV, smokers, alcoholics and other immunocomprimised individuals. The second 
manifestation of the disease, Pontiac fever, is a mild sickness. The symptoms include 
fever, dry cough, chillness, muscle pains, and headaches but no pneumonia (Pancer and 
Stypulkowska-Misiurewicz 2003).  
 
1.2 Pathogenesis of L. pneumophila 
 
L. pneumophila is transmitted to humans through the inhalation of contaminated aerosols 
into the lungs. L. pneumophila has the ability to cause disease because it survives inside 
the host cells by escaping the bacteriocidal activities of the alveolar macrophages (Horwitz 
and Silverstein 1980) and resembles its lifecycle in amoebae. After uptake into 
macrophages, L. pneumophila resides inside the phagosome and survives inside the host 
cell by inhibiting the phagosome-lysosome fusion and the early endocytic pathway 
(Horwitz 1983). L. pneumophila utilizes a specialized system to manipulate the functions 
of host effector proteins like Rab1 and Arf1 involved in vesicle trafficking and thereby 
recruiting the vesicles derived from endoplasmic reticulum (ER) and ribosomes to the 
Legionella containing vacuole (LCV).  Legionella makes use of the existing host 
machinery to form a specialized vacuole resembling the host rough endoplasmic reticulum 
(ER) studded with ribosomes (Derre and Isberg 2004). In the rough ER like vacuole, L. 
pneumophila replicates and eventually disrupts the vacuole membrane and lyses the host 
cell, which releases the bacterium into the extracellular environment for infecting 
neighbouring cells (Fig 1). 
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Figure 1: Life cycle of L. pneumophila after entry into a host cell. A bacterium of L. pneumophila is 
engulfed by macrophages by phagocytosis and resides in a phagsosme. Endoplasmic reticulum derived 
vesicles are recruited to fuse with the phagosome to form ER-like vacuoles studded with ribosomes, where L. 
pneumophila establishes replication niche and subsequently lyses the host cell. Avirulent strains of L. 
pneumophila (or other bacteria) fail to recruit ER-derived vesicles and enter the endocytic pathway, killing 
bacteria by phagosome-lysosome fusion. (adopted from Jiannin and Feng, 2011) 
 
1.3 Secretion Systems of L. pneumophila 
 
The interaction of a pathogen with its host is critical for its infection process. For this 
purpose, bacteria utilize specialized secretion systems to deliver virulence proteins into the 
cytosol of the host cells. In Gram-negative bacteria such as L. pneumophila, effector 
proteins need to cross the inner and the outer bacterial membrane, and the host plasma 
membrane to reach their destined location. This is accomplished by secretion machineries 
exist in the Gram-negative bacteria. L. pneumophila contains four secretion systems 
namely, type I Lss, type II pilD-dependent Lsp, type IVA Lvh, type IVB Icm/Dot and type 
V secretion system respectively (Gerlach and Hensel 2007). Among these, a type IV 
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secretion system is important for the virulence of L. pneumophila. Type IV secretion 
system are subdivided into type IVA and type IVB.  
 
1.3.0 Type IVA Secretion System (T4ASS) 
 
The T4ASS, resembles the Agrobacterium tumefaciens T-DNA transfer system or Vir 
system and is named as Legionella vir homologues (Lvh) system. Based on experimental 
evidences it was shown that L. pneumophila encodes 11 lvh genes (lvhB2, B3, B4, B5, B6, 
B8, B9, B10, B11, D4), and these are shown to be important in the virulence of L. 
pneumophila (Segal, Russo et al. 1999; Samrakandi, Ridenour et al. 2002). 
 
1.3.1 Type IVB Secretion System (T4BSS) 
 
The current work is mainly focused on effector proteins of T4BSS of L. pneumophila. 
Ralph Isberg and colleagues have identified approximately 20 L. pneumophila genes 
essential for intracellular replication and infection (Berger and Isberg 1994; Brand, 
Sadosky et al. 1994; Vogel, Andrews et al. 1998). Later these genes were collectively 
named dot (defect in organelle trafficking) or icm (intracellular multiplication). The 
dot/icm genes encode a T4BSS also known as Dot/Icm system, closely related to the Inc 
bacterial conjugative DNA-transfer systems (Segal and Shuman 1997; Vogel, Andrews et 
al. 1998). Several effector proteins of L. pneumophila are translocated into the cytosol of 
host cells using the Dot/Icm secretion system or T4BSS (Nagai, Kagan et al. 2002; Hubber 
and Roy 2010). 
 
The Dot/Icm system is composed of mainly two subcomplex units, the outer membrane 
core transport complex and the coupling protein complex. The outer membrane core 
transport complex is composed of DotC, DotD, DotF, DotG and DotH proteins in which 
the inner membrane proteins DotF (interacts with secreted substrates) and DotG 
(homology to the VirB10 protein of the A.tumefaciens) form a complex and the C-terminal 
domain of DotG interacts with the outer membrane complex DotC, DotD and DotH. DotC 
and DotD are the outer membrane lipoproteins that recruit DotH an intrinsic periplasmic 
protein to the outer membrane, thereby forming a DotC-DotD-DotH-DotF-DotG outer 
membrane core transport complex [Fig 2 (Vincent, Friedman et al. 2006)]. However, more 
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detailed study is needed to get a better understanding of the T4BSS or Icm/Dot secretion 
system of L. pneumophila. 
 
 
Figure 2: Components of type IVB secretion system (T4BSS) of L. pneumophila. The core transport 
complex that links the inner and outer membranes is composed of DotC, DotD, DotF, DotG and DotH [(Dot-
Defect in organelle trafficking). The inner membrane proteins DotF and DotG interact and form a 
subcomplex with the outer membrane lipoproteins DotC, DotD and DotH. The coupling protein complex is 
composed of DotL (recruits IcmSW substrates to the transport complex), DotM, DotN, IcmS and IcmW 
[adapted from (van Schaik, Chen et al. 2013)].  
 
To date biochemical, genetic and bioinformatics analyses have identified ~250 Dot/Icm 
substrate proteins (Nagai, Kagan et al. 2002; Conover, Derre et al. 2003; Luo and Isberg 
2004; Campodonico, Chesnel et al. 2005; de Felipe, Pampou et al. 2005; Ninio, Zuckman-
Cholon et al. 2005; Shohdy, Efe et al. 2005; Laguna, Creasey et al. 2006; Machner and 
Isberg 2006; Murata, Delprato et al. 2006; VanRheenen, Luo et al. 2006; Zusman, Aloni et 
al. 2007; Altman and Segal 2008; Kubori, Hyakutake et al. 2008; Zhu, Hu et al. 2010). The 
biochemical function of some substrates was identified while others remain to be studied. 
Some have C-terminal translocation signals for the substrate identification (Details are 
given in section 1.5). 
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1.4 Rab GTPases 
 
Eukaryotic cells consist of several distinct intracellular compartments, which require well 
defined regulation of transport of vesicles to their designated location (Jordens, Marsman 
et al. 2005). The process of membrane trafficking occurs in a series of steps, where the 
donor membranes protrude to form vesicles. Rab GTPases deliver these vesicles to the 
acceptor membranes via microtubules or actins by recruiting motor adaptor proteins. In the 
next step, vesicles fuse to their target membrane with the help of rod-shaped tethering 
factors and SNAREs (Soluble N-ethylmaleimide-sensitive factor attachment protein 
receptor) by a process called as tethering (Stenmark 2009). Cell biology studies on 
membrane trafficking have shown that Rab (Ras-related proteins in brain) GTPases are 
involved in regulating the membrane trafficking events by binding to the diverse group of 
effector proteins, motor proteins and tethering complexes (Segev 2001; de Renzis, 
Sonnichsen et al. 2002; Hammer and Wu 2002; Novick, Medkova et al. 2006; Cai, 
Reinisch et al. 2007).  
 
Rab proteins belong to the Ras super family of small GTPases (Wennerberg, Rossman et 
al. 2005). To date more than 60 Rab genes have been identified in the human genome 
(Pereira-Leal and Seabra 2000; Bock, Matern et al. 2001; Pereira-Leal, Hume et al. 2001). 
Rab proteins are located on the endoplasmic reticulum, Golgi apparatus, endosomes, 
lysosomes, nucleus, plasma membrane and mitochondria (Schwartz, Cao et al. 2007). Rab 
GTPases are involved in membrane trafficking, signalling events, regulation of cell 
proliferation and differentiation (Bucci and Chiariello 2006; Schwartz, Cao et al. 2007). 
 
Rab GTPases operate in two conformations, one is guanosinediphosphate (GDP)-bound 
‘inactive’ state and the other one is gunaosine triphosphate (GTP)-bound ‘active state’ 
(Stenmark, Valencia et al. 1994; Zerial and McBride 2001). Rabs do not exhibit high 
nucleotide exchange and hydrolysis activities, so the exchange of GDP to GTP or vice 
versa is accomplished by specialized proteins called guanine nucleotide exchange factors 
(GEFs) and GTPase-activating proteins (GAPs). In the cytosol, GDP Rab is solubilized by 
being in complex with guanine nucleotide dissociation inhibitor (GDI). For the membrane 
insertion of C-terminus of Rab, GDI need to be displaced from Rab:GDP and this is 
accomplished by GDI displacement factor (GDF) (Pfeffer and Aivazian 2004). Once 
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Rab:GDP is targeted to the membrane by GDF, GEF activates Rab by catalyzing the 
exchange of GDP for GTP. The GTP-bound active Rab interact with their downstream 
effector proteins to regulate several cellular functions such as membrane trafficking, 
signalling events, regulation of cell proliferation and differentiation. Eventually, the GTP-
bound ‘active’ Rab is converted back to the GDP-bound ‘inactive’ by the GAP, which 
 
 
Figure 3: Rab GTPase Cycle. Rab GTPases operate between GDP and GTP-bound forms. Exchange of 
GDP for GTP is catalyzed by the GDP/GTP exchange factor (GEF). The GTP-bound ‘active’ form interacts 
with its effector proteins and is converted back to the GDP-bound ‘inactive’ form by the GTPase activating 
protein (GAP), which promotes hydrolysis of GTP and releases an inorganic phosphate (Pi). Rab escort 
protein (REP) presents the newly synthesized GDP-bound Rab to a prenylating enzyme Rab 
geranylgeranyltransferase (RabGGTase), which geranylgeranylates one or two carboxy-terminal Cys 
residues of the Rab. The geranylgernaylated, GDP-bound Rab is further recognized by Rab GDP dissociation 
inhibitor (GDI). The GDI displacement factor (GDF), releases GDI from the Rab-GDI complex and recruits 
GDP-bound Rab to the target membrane [adapted from (Stenmark and Olkkonen 2001). 
 
effector proteins to regulate several cellular functions such as membrane trafficking, 
signalling events, regulation of cell proliferation and differentiation. Eventually, the GTP-
bound ‘active’ Rab is converted back to the GDP-bound ‘inactive’ by the GAP, which 
facilitates the hydrolysis of GTP by releasing inorganic phosphate (Pi). The Rab GTPase 
cycle is circumvented by the extraction of Rab:GDP from the target membrane to the 
cytoplasm by GDI [(Fig 3) (Somsel Rodman and Wandinger-Ness 2000; Esters, 
Alexandrov et al. 2001; Gurkan, Lapp et al. 2005)].  
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Rab GTPases are targeted to specific membranes by a post-translational modification 
known as prenylation, where 20-carbon geranylgeranyl group is attached to one or two 
carboxy-terminal Cys residues of the Rab (Andres, Seabra et al. 1993). The prenylation of 
Rab GTPases is carried out by two conserved paralogs, Rab escort protein (REP) and Rab-
GDI (Alory and Balch 2001; Pereira-Leal, Hume et al. 2001). REP is responsible for 
presenting the newly synthesized Rab proteins to the prenylating enzyme Rab 
geranylgeranyltransferase (RabGGTase) for geranyl-geranylation process and then delivers 
Rab proteins to target membranes. Rab GDI is important for Rab recycling by extracting 
inactive Rab proteins from membranes after GTP hydrolysis. The GDF, releases GDI from 
the Rab-GDI complex and recruits GDP-bound Rab to the target membrane (Ullrich, 
Stenmark et al. 1993; Sivars, Aivazian et al. 2003). REP binds either prenylated or 
unprenylated GDP bound Rab proteins with high affinity, whereas GDI binds prenylated 
Rab with higher affinity than to unprenylated Rab proteins (Plutner, Cox et al. 1991; Wu, 
Tan et al. 2007). 
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1.4.1 Structure of Rab GTPases 
 
 
Figure 4: Crystal structures of Rab GTPases in GDP-bound, inactive and GTP-bound active 
conformation. (A) Structure of Rab1A bound to GDP and Mg2+ showing switch II in disordered 
conformation (Left). Structure of Ypt1:Guanosine 5′-[β, γ-imido] triphosphate (GppNHP: non- hydrolyzable 
analogue of GTP) showing switch II adopted ordered confirmation (Right). (B) Several Rab GTPase 
structures in active and inactive bound conformations are aligned showing structural differences (Left: GDP 
bound inactive conformations, Right: GTP bound active conformations). Structural elements; P-loop 
coloured in magenta, switch I in blue, switch II in red and interswitch regions in orange, GDP and Mg2+ are 
shown in stick and sphere representation (Details of the above structures are given in Table 1). 
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Table 1: Structures of Rab GTPases represented in Figure 4 are summarized below 
Protein Ligand PDB ID 
 
Rab/GDP (Fig 5) 
  
Rab1A GDP 2FOL 
Rab2A GDP 1Z0A 
Rab3B GDP 3DZ8 
Rab3D GDP 2GF9 
Rab4B GDP 2O52 
Rab5B GDP 2HEI 
Rab5C GDP 1ZOD 
Rab6A (Q72L) GDP 4DKX 
Rab7 GDP 1VG1 
Rab12 GDP 2IL1 
Rab14 GDP 1ZOF 
Rab21 GDP 1ZOI 
Rab23 GDP 1Z22 
Rab25 GDP 2OIL 
Rab43 GDP 2HUP 
 
Rab/GTP /GppNHP 
(Fig 5) 
  
Ypt1 GppNHP 1YZN 
Rab3A GppNHP 3RAB 
Rab4A GppNHP 2BME 
Rab6A GTP 2GIL 
Rab6 GppNHP 1YZQ 
Rab7 GppNHP 1VG8 
Rab28 GppNHP 3E5H 
Ypt7 GppNHP 1KY2 
Ypt51 GppNHP 1EKO 
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Rab/GDI/REP(Fig 6) 
Rab7/REP1 GDP 1VGO 
REP1/RabGGTase  1LTX 
Ypt1/GDI GDP 1UKV 
 
 
Rab proteins exhibit common structural features of Ras-related GTPases, comprising of a 
six-stranded-β sheet, with five parallel strands and one antiparallel strand, enclosed by five 
α- helices (Vetter and Wittinghofer 2001). Crystallographic analysis of various Rabs in the 
GDP- and GTP-bound states shows that the protein adopts two different conformations and 
these conformational changes are confined to two regions namely switch I and switch II 
(Fig 4 A&B). Magnesium ions (Mg2+) are important for the high affinity binding of 
nucleotide to the Rab GTPases. Guanine nucleotides interact with residues from five G-
motifs that are highly conserved in all GTPases. The G1 motif also commonly known as P-
loop (phosphate binding loop) consists of consensus sequence GxxxxGKS/T that binds to 
phosphate and Ser/Thr is coordinated by the Mg2+. The G2 motif in the switch I region has 
threonine residue that interacts with γ-phosphate and the Mg2+ ion. The G3 motif in the 
switch II region has a conserved DxxGQ sequence where the aspartate establishes water 
mediated ionic interaction with Mg2+, the glycine interacts with the γ-phosphate and the 
glutamine acts as a catalytic residue for the GTP hydrolysis. The residues in the G4 and G5 
motifs interact with the guanine base and also distinguish from other nucleotides 
(Khosravi-Far, Lutz et al. 1991; Vetter and Wittinghofer 2001).  
Several crystal structures are available for RabGTPases in the GDP bound inactive state 
and GTP bound active state (Table 1). In the GDP bound inactive state, the switch regions 
are largely disordered or adopts ordered conformations based on the crystal packing, where 
in the GTP-bound active state, the switch regions adopts ordered conformation [(Eathiraj, 
Pan et al. 2005) (Fig 4B)]. 
 
1.4.2 Rab activation by GEFs 
 
As explained in the previous section, activation of Rab GTPases is regulated by the switch 
between GDP bound inactive state and GTP bound active state. Rab GTPases form 
multiple contacts with guanosine nucleotides involving G motifs and Mg2+. The affinity of 
GDP to Rab family is high and hence the release of GDP from Rab GTPases occurs at a 
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very slow rate by itself and this process is accelerated by GEF. GEFs establish competition 
with nucleotides for binding to GTPases. To date only few Rab GEFs have been identified 
because of their diversity in the sequence, structure, size and complexity (Lee, Mishra et 
al. 2009). Structures of five Rab-GEFs in complex with their specific Rab GTPases have 
been determined. They are MSS4-Rab8, Sec2p-Sec4p, Rabex-5-Rab21, TRAPP1-Ypt1p 
and DENN1B-S-Rab35. These structures will be explained in detail in the discussion 
chapter. Briefly, based on the available structural information about GEF-GTPase 
complex, it was explained that GEFs induces structural changes on Rab GTPases, 
especially on the nucleotide binding sites of switch I and switch II regions. These structural 
rearrangements lead to the wide opening of the nucleotide binding pocket and release of 
Mg2+. This results in reducing the binding affinity between nucleotide and Rab GTPases.  
 
1.5 Hijacking of Rab GTPases by L. pneumophila 
L. pneumophila able to survive inside the host cell by modulating several functions of host 
proteins by delivering large set of effector proteins in to the host cytosol via T4BSS also 
known as Dot/Icm.  Some of the Dot/Icm effector proteins namely SidM/DrrA, SidD and 
LepB mimic the function of host GEF, GAP and GDF proteins that are involved in the 
activation and inactivation of Rab1 GTPase.  
 
1.5.1 SidM/DrrA 
 
 
Figure 5: Domain organization of SidM/DrrA. N-terminus harbouring AMPlyation domain, central part 
with GEF domain and C-terminal P4M domain 
 
SidM, a Dot/Icm effector protein of L. pneumophila recruits Rab1 onto the LCV. Rab1 is a 
small GTPase involved in the regulation of vesicle trafficking between ER and Golgi 
complex. SidM also named as DrrA contains 647 amino acid residues comprises of three 
domains: a C-terminal novel phosphatidylinositol 4-phosphatase (PI(4)P)-binding domain, 
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a central domain exhibiting GEF and GDF activity for Rab1 and an N-terminal domain 
displaying adenylyl transferase (AMPylation) activity (Fig 5). Inside the host cell, SidM is 
anchored to the LCV by the action of PI4P domain that binds with high affinity to PI4P 
located on the vacuolar membrane (Brombacher, Urwyler et al. 2009; Schoebel, 
Blankenfeldt et al. 2010; Zhu, Hu et al. 2010). The central GEF/GDF domain of SidM 
enables the recruitment of Rab1 to the LCV by detaching GDI from Rab:GDP:GDI 
complex and activates Rab by catalyzing the GDP/GTP exchange (Machner and Isberg 
2006; Murata, Delprato et al. 2006; Ingmundson, Delprato et al. 2007). The N-terminal 
domain with adenylation activity catalyses transfer of adenosine mono phosphate (AMP) 
to a conserved Tyr 77 in the switch II region of Rab1:GTP. This modification inhibits the 
hydrolysis of GTP to GDP, maintaining Rab1 in the active form (Muller, Peters et al. 
2010). By the action of SidM, Rab1 efficiently remodulates the LCV into an ER- like 
derived vesicle, where L. pneumophila replicates and escapes the lysosomal fusion. This is 
how the multi functional SidM/DrrA is important for the pathogenicity of L. pneumophila. 
 
Figure 6: Regulation of Rab1 activity cycle by Dot/Icm effector proteins of L. pneumophila on the 
LCV. L. pneumophila secretes effector proteins into the host cytosol via T4BSS or Dot/Icm. SidM is 
anchored to the LCV by PI(4)P binding to recruit GDP-bound Rab1 to the LCV by detaching it from the 
Rab1-GDI complex and later activates Rab1 by catalyzing the exchange of GDP for GTP. SidM then 
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AMPylates (adding AMP) GTP-bound Rab1 at Tyr 77 to retain Rab1 in its active form, which is not 
accessible to GAPs. SidD deAMPylates (remove AMP) Rab1, which makes it accessible for inactivation by 
LepB mediated GTP hydrolysis. Finally, inactive GDP-bound Rab is accessible for GDI to remove it from 
the LCV membrane [Adopted from (Neunuebel and Machner 2012)] . 
 
1.5.2 SidD, LepB, and LidA 
 
SidD is another Dot/Icm effector protein consisting of 507 amino acids, deAMPylates 
Rab1 by harbouring protein phosphatase-like catalytic domain (Neunuebel, Chen et al. 
2011; Tan and Luo 2011). SidD makes Rab1 accessible for inactivation by LepB. LepB 
also a T4B effector protein exhibits GAP activity and inactivates Rab1 by promoting 
hydrolysis of GTP to GDP and removes Rab1 from the LCV (Ingmundson, Delprato et al. 
2007).  The inactive GDP-bound Rab1 is extracted from the membrane by the action of 
GDI. LidA, the other T4B effector protein binds to various Rabs regardless with the bound 
nucleotide form, but shows higher affinity towards Rab1-GTP (Conover, Derre et al. 2003; 
Machner and Isberg 2006). LidA is also thought to involve in assisting SidM for the 
recruitment of Rab1 onto the LCV and in maintaining bacterial cell integrity (Machner and 
Isberg 2006; De Buck, Anne et al. 2007).  The mechanism of its function is not clearly 
known.  
The combined action of SidM/DrrA catalysed nucleotide exchange and AMPylation, SidD 
catalyzed deAMPylation and LepB-catalysed GTP hydrolysis of Rab1A explains the 
unique mechanism of L. pneumophila in regulating the Rab1 cycle (Fig 6). 
 
1.6 Aim of the work 
 
The T4B or Icm/Dot effector protein SidM of L. pneumophila is shown to have GEF and 
GDF activity towards Rab1 GTPase. One aim of this work is to produce and purify 
SidM317-545 and Rab1a to analyse the stable complex formation of two proteins by size 
exclusion chromatography (SEC) and Isothermal titration calorimetry (ITC). The second 
aim is to solve the crystal structure of SidM317-545 and SidM317-545/Rab1a complex by X-ray 
crystallography to elucidate the mode of interaction between two proteins.  
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2 Materials and Methods 
 
2.1 Standard Materials 
If not mentioned otherwise, all chemicals and reagents used were purchased from Qiagen, 
Sigma Aldrich, Fluka, Invitrogen, GE Healthcare, Millipore, Hampton Research, Roche, 
Merck, Stratagene, Pall and Inqaba Biotech. 
 
2.1.1 Chemicals, Enzymes and Kits 
 
Table 1: Enzymes  
 
Enzyme Source 
Benzonase Structural Biology Group, HZI 
DNaseI Roche 
PreScission Protease Structural Biology Group, HZI 
TEV protease Structural Biology Group, HZI 
Pfu DNA polymerase Invitrogen 
DpnI Fermentas 
T4 DNA Ligase 
Hen egg-white lysozyme (HEWL) 
Restriction endonucleases: 
BamHI, EcoRI, NcoI, NdeI and XhoI 
New England Biolabs 
Fluka 
New England Biolabs 
 
 
2.1.2 Molecular Weight Standards and Kits 
 
Table 2: Molecular weight standards  
 
Name  Type Usage Company 
Smart Ladder DNA Agarose gel electrophoresis Fermentas 
Prestained protein Marker Protein SDS-PAGE Fermentas 
Unstained protein Marker Protein SDS-PAGE Fermentas 
 
 
Table 3: Kits 
 
Kits Source 
QIAprep Spin Miniprep Kit Qiagen 
QIAquick PCR Purification Kit Qiagen 
QuickChange Site-Directed Mutagenesis 
Kit 
Stratagene 
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2.1.3 Crystallization Screens 
 
The following commercial screens were used to screen for initial crystallization conditions. 
 
Table 4: Crystallization screens  
 
Crystallization kits Source 
The AmSO4 Suite  
The Compas Suite  
The Cryo Suite  
The Classic I–II Suite  
The Classic Lite Suite  
The JCSG+ Suite Qiagen 
The JCSG I-IV Suite  
The PACT Suite  
The PEGs Suite  
The pH Suite  
The Pro-complex Suite  
The MPD Suite  
Pre-crystallization Test   
Additive Screen Hampton Research Corp. 
Detergent Screen  
Grid Screen Ammonium Sulfate  
 
 
2.1.4 Oligonucleotides 
 
Primers used for site-directed mutagenesis and PCR reactions were purchased from MWG 
and Inqaba Biotech (desalted and HPLC-purified).  
 
Table 5: Oligonucleotides for PCR and site-directed mutagenesis. Point mutations are highlighted bold 
and underlined.  
 
Primer  Length 
(bp) 
Sequence 
Rab1A C178S C179S 47 5’ CAAGCAGTCAGGTGGAGGTTCCTCCCATCATCATCATCATCATTAAC 3’ 
Rab1A 5aaΔ 42 5’ TTAAAATTCAGAGCACTGGTGGAGGTTCCTCCCATCATCATC 3’ 
Rab1A 10aaΔ 41 5’ TGCTGAGAAGTCCAATGTTGGTGGAGGTTCCTCCCATCATC 3’ 
Rab1A 15aaΔ 35 5’ AGCAACAGCTGGTGGTGCTGGTGGAGGTTCCTCCC 3’ 
Rab1A 18aaΔ 35 5’ TCCCCGGAGCAACAGCTGGTGGAGGTTCCTCCCATC 3’ 
Rab1A 20aaΔ 38 5’ AATGGGTCCCGGAGCAGGTGGAGGTTCCTCCCATCATC 3’ 
Rab1A 23aaΔ 42 5’ CTGAGATTAAAAAGCGAATGGGTGGTGGAGGTTCCTCCCATC 3’ 
Rab1A His Stop 35 5’ GATTAAAAAGCGAATGCCGTGAGGTTCCTCCC 3’ 
Rab1AK56AK58S 49 5’ GAGTTAGACGGGGCAACAATCAGTCTTCAAATATGGGACACAGCAGGCC 3’ 
Rab1AK128S K129S 49 5’ GGAACAAATGTGATCTGACCACAGCGAGCGTAGTAGACTACACAACAGC 3’ 
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Rab1A E168A K170S 
K171A R172S 
53 5’ CATGACGATGGCAGCTGCGATTAGTGCGAGAATGGGTGGTGGAGGTTCCTCCC 3’ 
Rab1A D16A 28 5’ TTACTTCTGATTGGCGCATCAGGGGTTG 3’ 
Rab1A E35A 33 5’ GCAGATGATACATATACAGCAAGCTACATCAGC 3’ 
Rab1A Y37A 31 5’ CATATACAGAAAGCGCCATCAGCACAATTGG 3’ 
Rab1A I41A 30 5’ GCTAACATCAGCACAGCAGGTGTGGATTTC 3’ 
Rab1A W62A 29 5’ GCTTCAAATAGCCGACACAGCAGGCCAGG 3’ 
Rab1A R69A 30 5’ GCAGGCCAGGAAGCATTTCGAACAATCACC 3’ 
pETM30-SidM FW 46 5’CGTTTGGTGGTGGCGACCATCCTCTGGAAGTTCTGTTCCAGGGGCC 3’ 
pETM30-SidMRV 52 5’ CTCAGTGGTGGTGGTGGTGGTGTTATTTTATCTTAATGGTTTGTCTTTCTTG 3’ 
SidM E337A E340A 
K343S K344A 
53 5’ CGTGTCACAAGGATTGCAAATCTGGCAAATGCCAGCGCGTTGTGGGACAACGC 3’ 
SidM (K454A K457S 
K459A) 
54 5’ GCGAGCAACCCCTGATCCAGATTTTGCGGTTGGGAGCTCTGCAATTTTAGTAGG 3’ 
 
 
2.1.5 Plasmids 
 
Table 6: Plasmids  
 
Plasmid Size (Kb) Selection Tag Position Cleavage site Source 
pGEX-6P-
1 
     4.9 AmpR GST N-terminal PreScission   
Protease 
GE 
Healthcar
e 
pETM-30      6.3 KanR GST 
 
His6 
N-terminal 
C-terminal 
TEV Protease EMBL, 
Protein 
Expressio
n Facility 
pET-21      5.4 AmpR His6 C-terminal  Novagen 
 
2.1.6 Recombinant Plasmids 
 
Recombinant plasmids used in this work are summarized in Table 7 
 
Table 7: Recombinant plasmids 
Plasmid Features Source 
pGEX-6P-1_sidM317-
545 
684 bp BamHI/HindIII fragment 
of sidM (317-545) in  pGEX-6P-1 
MP Machner,  
NICHD, USA 
 
pGEX-6P-1_rab1A1-
210 
630 bp BamHI/HindIII fragment 
of rab1A (1-210) in  pGEX-6P-1 
MP Machner,  
NICHD, USA 
pGEX-6P-1_rab1A1-
200 
Site-directed mutagenesis of  
pGEX-6P-1_rab1A1-210 
this work 
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2.1.7 Bacterial Strains 
 
The following bacterial strains were used  
 
Table 8: Bacterial strains  
 
E.coli strains Antibiotic Resistance  Source 
Rosetta 2 (DE3) Chloramphenicol  Novagen 
Top 10   Invitrogen 
XL1 Blue super 
competent cells 
Ampicillin  Stratagene 
BL21  Ampicillin  Stratagene 
BL21 (DE3) codon 
plus 
Chloramphenicol  Stratagene 
 
 
 
 
pGEX-6P-1_rab1A1-
195 
Site-directed mutagenesis of  
pGEX-6P-1_rab1A1-210 
 
this work  
pGEX-6P-1_rab1A1-
190 
Site-directed mutagenesis of  
pGEX-6P-1_rab1A1-210 
 
this work 
pGEX-6P-1_rab1A1-
187 
Site-directed mutagenesis of  
pGEX-6P-1_rab1A1-210 
 
this work 
pGEX-6P-1_rab1A1-
175 
Site-directed mutagenesis of  
pGEX-6P-1_rab1A1-210 
 
this work 
pGEX-6P-
1_rab1AK55A/K58S 
Site-directed mutagenesis of  
pGEX-6P-1_rab1A1-210 
 
this work 
pGEX-6P-
1_rab1AK168A/K172S 
Site-directed mutagenesis of  
pGEX-6P-1_rab1A1-210 
 
this work 
pGEX-6P-
1_rab1AD16A 
Site-directed mutagenesis of  
pGEX-6P-1_rab1A1-175 
 
this work 
pGEX-6P-
1_rab1AE35A 
Site-directed mutagenesis of  
pGEX-6P-1_rab1A1-175 
this work 
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2.1.8 Other Chemicals 
 
Table 9: Other chemicals  
Chemical Source 
Complete-Protease Inhibitor Cocktail 
Tablets 
Roche 
Complete-EDTA free Protease Inhibitor 
Cocktail Tablets 
Roche 
Bug Buster Protein Extraction Reagent Novagen 
 
 
2.1.9 Antibiotics 
Table 10: Stock solutions of antibiotics 
Antibiotic Final concentration 
Ampicillin 100 µg/mL in H2O 
Chloramphenicol 34 µg/mL in ethanol 
Kanamycin 30 µg/mL in H2O 
 
 
2.2 Media and Buffers 
Media and buffers used in this study are summarized in Table 11 and Table 12. All media 
were sterilized by autoclaving while heat-sensitive components were sterile filtered (0.2 
µM filters). Antibiotics were added after media had been allowed to cool to below 50 °C.  
 
Table 11: Media 
 
Culture Media Ingredients Final 
concentration 
Luria Bertani Medium (LB) Bactotryptone 
Yeast extract  
NaCl 
10 g/L 
5 g/L 
10 g/L 
 
 
SOB-Medium Bactotryptone  
Yeast extract  
NaCl 
KCl 
20 g/L 
5 g/L 
10 mM 
2.5 mM 
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SOC-Medium Tryptone 
Yeast extract 
NaCl 
KCl 
MgCl2 
Glucose 
 
20 g/L 
5 g/L 
10 mM 
2.5 mM 
10 mM 
20 mM 
   
 
Table 12: Solutions and buffers 
Buffers/Solutions Composition 
Lysis buffer 
 
1 x PBS (Phosphate Buffered Saline) pH 
7.0, 2.5 mM MgCl2,  Complete EDTA-free 
Protease Inhibitor Cocktail Tablet, 5 mM β-
mercaptoethanol and DNaseI (10 µg/mL) 
PreScission protease cleavage buffer 10 mM Tris/HCl pH 7.0, 150 mM NaCl, 5 
mM β-mercaptoethanol 
Ni-NTA binding buffer 1 x PBS pH 7.0, 10 mM imidazole, 5 mM β-
mercaptoethanol,   
Ni-NTA elution buffer 1x PBS pH 7.0, 250 mM imidazole, 5 mM 
β-mercaptoethanol 
TEV cleavage buffer 50 mM Tris/HCl pH 7.5, 150 mM NaCl, 
20 mM EDTA, 5 mM β-mercaptoethanol 
Anion exchange buffer A1 (Rab1A) 20 mM Tris/HCl pH 7.0, 10 mM NaCl, 
5 mM β-mercaptoethanol 
Anion exchange buffer B1 (Rab1A) Buffer A1 (Rab1A) + 1 M NaCl 
Cation exchange buffer A1 (SidM) 20 mM Tris/HCl pH 8.0, 10 mM NaCl, 
5 mM β-mercaptoethanol 
Cation exchange buffer B1(SidM) Buffer A1 (SidM) + 1M NaCl  
Anion exchange buffer A2 (Rab1A/SidM) 20 mM Tris/HCl pH 7.0, 10 mM NaCl, 
5 mM β-mercaptoethanol 
Anion exchange buffer B2 (Rab1A/SidM) Buffer A1 (Rab1A/SidM) + 1M NaCl 
Gel filtration buffer (Rab1A/SidM) 50 mM Tris/HCl pH 7.5, 150 mM NaCl, 5 
mM β-mercaptoethanol 
ITC buffer 50 mM HEPES pH 8.0, 50 mM NaCl 
TAE buffer  40 mM Tris/HCl pH 7.5, 20 mM sodium 
acetate, 1 mM EDTA. Adjust pH to 8.2 with 
acetic acid 
10 x DNA loading buffer 70 % (w/v) sucrose, 0.25 % (w/v) 
bromphenol blue, 0.1 M EDTA 
SDS-PAGE lower buffer (4 x) 1.5 M Tris/HCl pH 8.8 
SDS-PAGE upper buffer (4 x) 0.5 M Tris/HCl pH 6.8, 0.4 % (w/v) SDS 
SDS-PAGE running buffer 25 mM Tris/HCl, 192  mM glycine, 0.1 % 
(w/v) SDS 
SDS-PAGE sample buffer (8 x) 16 mL 10 % SDS, 4 mL glycerol, 2.2 mL 
Tris/HCl, pH 6.8, 800 µL 
β-mercaptoethanol, 
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1 spatula tip bromophenol blue 
 
SDS-PAGE separating gel (15 %) 15 mL acrylamide/bisacrylamide 30 % 
(w/v)/ 0.8 % (w/v), 7.6 mL 1.5 M Tris/HCl, 
pH 6.8, 300 µL 10 % (w/v) SDS, 10 mL 
ddH2O, 40 µL TEMED, 100 µL 25 % (w/v) 
APS 
 
SDS-PAGE stacking gel (5 %) 1.5 mL acrylamide/bisacrylamide 30 % 
(w/v)/0.8 % (w/v), 2.5 mL 0.5 M Tris/HCl, 
pH 6.8, 5.9 mL ddH2O, 15 µL TEMED, 25 
µL 25 % (w/v) APS 
 
SDS-PAGE Staining solution 0.25 % (w/v) Coomassie Brilliant Blue R-
250, 30 % (v/v) ethanol, 10 % (v/v) acetic 
acid 
 
SDS-PAGE destaining solution 40 % (v/v) ethanol, 10 % (v/v) acetic acid 
 
 
 
2.3 Microbiology 
2.3.1 Preparation of Agar Plates 
Agar plates were used to culture bacteria on solid medium. Agar plates were prepared 
following standard procedure: 15 g agar was added to 1 L LB-medium. The solution was 
sterilized by autoclaving and allowed to cool to ~55 °C. Required antibiotics were added 
and 25 mL of agar was poured into each Petri dish). Bacteria were plated on LB agar plates 
with respective antibiotics on a sterile clean bench with sterile beads or spreading 
inoculation loops.  
 
2.3.2 Liquid culture  
Bacteria were grown in liquid medium using Erlenmeyer flasks for proper aeration and 
agitation. The flasks containing inoculated liquid medium with appropriate antibiotics were 
incubated at 37 °C with a rotation speed of 160-180 rpm overnight. Liquid bacterial 
cultures were made for precultures, protein production, preparation of DNA and glycerol 
stocks. 
 
2.3.3 Preparation of Glycerol Stocks 
Glycerol stocks were prepared for long-term storage of the bacterial cells containing 
plasmid of interest. 5 mL LB-medium was inoculated with bacteria harboring a plasmid of 
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interest. Appropriate antibiotics were added and incubated overnight at 37 °C and a 
rotation speed of 160-180 rpm. 900µL of this culture was mixed with 100 µL of sterile 80 
% glycerol (cryoprotectant) in a 1 mL cryo-vial and then stored at -80 °C. 
 
2.4 Molecular Biology 
2.4.1 Transformation of Competent Bacteria 
Competent bacterial cells were transformed with plasmid DNA for plasmid amplification 
and recombinant gene expression. Positive clones were selected by plating the 
transformation mixture on LB agar plates containing antibiotics corresponding to plasmid 
resistance genes.  
Heat shock transformation 
Plasmid DNA (1-2 µL) obtained from ligation reactions was added to 50 µL of competent 
cells that were thawed on ice. The cells were incubated on ice for 30 minutes and treated 
with heat shock for 45 s at 42 °C, followed by fast cooling on ice for 2 min. 800 µL of 
SOC or LB medium were added to the cells and shaken at 37 °C for 1 h on a thermo-
mixer. The transformation mixture was plated on LB agar plates containing appropriate 
antibiotics and incubated at 37 °C overnight. 
 
Electroporation 
Plasmid DNA (1-2 µL) was transferred in to a pre-cooled electroporation cuvette, followed 
by the addition of 50 µL competent cells (thawed on ice). The cuvette was dried and an 
electric pulse of 2.5 kV, 200 Ω and 125 µF was applied to the cells using Gene Pulser 
electroporation equipment (Bio-Rad). 800 µL of SOC or LB-medium was added 
immediately to the cells and incubated at 37 °C for 1h on a thermo-mixer. The 
transformation mixture was plated on LB agar plates using appropriate antibiotics. 
 
2.4.2 Extraction of Plasmid DNA 
Freshly transformed E. coli XL1 blue cells were transferred to 5 mL of LB medium with 
appropriate antibiotics and allowed to grow at 37 °C in a shaking incubator overnight. 
Plasmid DNA was isolated using QIAGEN mini prep kit. Purification of the plasmid DNA 
was performed according to the manufacturer’s instructions. The yield of DNA was 
measured by detecting the absorption at 260 nm (A260) using a Nanodrop ND-1000 
spectrophotometer (peqLab, Erlangen, Germany) 
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2.4.3 Agarose gel electrophoresis 
Agarose gel electrophoresis is a common method for analyzing DNA samples. In this 
method, DNA migrates through the agarose matrix when an electric current is applied. 
Phosphate groups on the DNA impart a negative charge to the molecule and migrate 
towards a positively charged pole. 1 % agarose gel was prepared by dissolving 0.5 g of 
agarose in 50 mL of TAE buffer, brought to boil in a microwave for 1min. The agarose 
solution was allowed to cool down to ~60 °C and SYBR Green was added to visualize the 
DNA samples. DNA samples were mixed with 10 % loading buffer (10 x) and loaded into 
the sample wells. Gels were run at 5 V/cm for 60 min and later visualized under a UV 
illuminator.  
 
2.4.4 Site-directed mutagenesis  
Site-directed mutagenesis is a technique to replace, delete or insert a number of nucleotides 
into a target DNA by PCR using appropriately designed primers. Mutagenesis reactions 
were performed using the Quick Change Kit (QIAGEN). The reaction products were 
treated with DpnI restriction enzyme for 1 h at 37 °C to digest the methylated template 
DNA. The DpnI digested products were transformed into XL1 blue competent cells. The 
transformation mixture was plated on LB agar plates with appropriate antibiotics. Positive 
clones were analyzed by DNA sequencing. Given below are the parameters for PCR 
 
Table 13: Reaction mixture  
Reaction components Volume (µL) Concentration 
10x PFU Ultra II buffer  10.0 1 x 
Template DNA 1.0 50 ng 
Mutagenesis forward primer  1.25 10 pmol/µL 
Mutagenesis reverse primer  1.25 10 pmol/µL 
dNTP’smix  1.0 10 µM 
Pfu Ultra HS II DNA-
polymerase (Stratagene) 
1.0 1 U 
Total volume 50.00  
 
 
 
Table 14: Mutagenesis reaction programme 
Step1 Initial denaturation 95 °C 1 min 
Step2 Denaturation 95 °C 50 s 
Step3 Annealing 55°C  50 s 
Step4 Elongation 68 °C 7 min 
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Step5 Final elongation 68 °C 9 min 
Repeat steps 2-4 18 times   
 
 
2.4.5 Restriction free cloning 
Restriction free (RF) cloning is a simple method compared to conventional cloning 
whereby a gene of interest can be inserted at any desired location into a vector, 
independent of restriction sites, ligation or any modifications in both vector and gene. In 
this work, the gene sidM was cloned into pETM-30 vector using this method. A set of 
primers 50 bases in length were designed harboring complementary sequences to both 
sidM and to the vector. The forward primer had an overlap of 24 bases with the vector 
sequence complementary to the 5’-end of the target site of insertion, followed by a start 
codon and 20-25 bases of the 5’-end of sidM. The reverse primer of 24 bases was 
complementary to the 3’ end of the vector at the target site of insertion (Fusinita et al., 
2006). The reaction mixture containing the template, primers, dNTP’s, polymerase and 
buffer was amplified by PCR and the resultant products were analyzed by agarose gel 
electrophoresis. The double-stranded, blunt-ended PCR product was used as a set of 
primers for a second PCR to insert the amplified gene into the desired vector. The final 
product was digested with DpnI for 1 h at 37 °C and transformed into XL1 blue cells. 
Positive clones were analyzed by DNA sequencing. 
 
2.4.6 Co-expression  
The vectors pGEX-6P-1_Rab1A1-210 and pETM30_SidM317-545 were co-transformed into E. 
coli BL21-CodonPlus cells (Stratagene) for co-expression of the two respective genes. The 
transformation mixture was plated on LB-agar plates containing ampicillin, kanamycin and 
chloramophenicol. Positive clones were confirmed by protein expression test. 
 
2.5 Protein Production and Purification 
2.5.1 Expression Test 
To optimize the expression of a target recombinant gene (Table 8), various parameters 
such as temperature, isopropyl-β-D-1-thiogalacto pyranoside (IPTG) concentration and 
induction time were tested. The recombinant plasmids harboring a gene of interest (Table 
8) were transformed into E. coli BL21 and/or Rosetta 2 expression cells. In each case, a 
single colony was picked from the LB agar plate and transferred to 5 mL of LB-medium 
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with appropriate antibiotics and grown overnight at 37 °C in a shaking incubator. The 
overnight pre-culture cells were transferred into 50 mL of LB-medium with appropriate 
antibiotics and incubated at 37 °C, 180 rpm until cell density reached an OD600 value of 
0.5-0.8. Expression of the target genes was induced with 0.1 mM IPTG. Samples were 
taken before induction and every 2 h after induction i.e. at 2, 4, 6 h and overnight. Samples 
were then centrifuged for 1 min at 13000 rpm. The bacterial pellet containing total cell 
extract was resuspended in 100 µL Bug-Buster reagent and incubated at room temperature 
for 20 min, followed by centrifugation for 20 min at 13000 rpm. The supernatant 
containing all soluble proteins was collected for the analysis of the target recombinant 
protein production. The pellet was resuspended in an equal volume of 8 M urea. Samples 
of the soluble and insoluble fractions were analyzed by SDS-PAGE. 
 
 
2.5.2 Recombinant Protein Production  
In this work pGEX-6P-1_SidM317-545, pGEX-6P-1_Rab1A1-210 and pGEX-6P-1_Rab1A 
plasmid constructs were expressed in E. coli. BL21, BL21-CodonPlus and Rosetta 2. Cells 
harboring the respective recombinant plasmids were thawed from glycerol stocks and 
grown in 50 mL LB-medium containing appropriate antibiotics at 37 °C and 180 rpm 
overnight. The resulting 0.1 OD600 pre-culture was transferred to 2 L of LB-medium with 
appropriate antibiotics. The cells were permitted to grow at 37 °C and 180 rpm until they 
reached an OD600 of 0.5-0.8. The expression of the gene of interest was induced by 0.1 mM 
IPTG and the cultures were incubated at 18, 25, 37 °C, 180 rpm respectively. After 
overnight incubation, cells were harvested by centrifugation: 15 min, 4 °C, 6000 rpm. The 
supernatant was discarded and the cell pellet resuspended in 15 mL lysis buffer per 1 L 
culture at 4 °C. The cell suspension was passed through a homogenizer (Constant systems 
20 kPa, 4 °C, 2-3 runs for efficient cell lysis. After cell lysis DNase I was added to degrade 
DNA and reduce sample viscosity. The lysate was centrifuged for 1 h at 4 °C and 16000 
rpm to separate the soluble protein fraction from cell debris and inclusion bodies. Soluble 
and insoluble fraction samples were collected to analyze the target protein production by 
SDS-PAGE. 
 
 
 
32	  	  
2.5.3 Purification of Rab1A and SidM317-545   
 
Affinity chromatography 
Affinity chromatography is based on the principle of strong and specific binding of affinity 
tag fused to the N- or C-terminus of the target protein to an immobilized matrix. In this 
work, the central domain of SidM317-545 was produced as a fusion protein with an N-
terminal glutathione S-transferase (GST) tag whereas Rab1A1-210 and variants were 
produced with an N-terminal GST and a C-terminal His6-tag.  
 
Glutathione/Glutathione-S-Transferase Affinity Chromatography 
This method is based on the high affinity of GST for its substrate glutathione. GST is used 
as an affinity tag fused to a target protein. In this work, both SidM and Rab1A were 
purified by producing N-terminal GST fusion proteins. After cell lysis, the soluble fraction 
was added to the PBS pre-equilibrated glutathione sepharose (GS) beads and incubated at 4 
°C for 1 h with agitation to allow the target protein to bind. The flow through was collected 
to check for possible unbound fusion protein. Loaded GS beads were washed 4 times (50 
mL) with PBS buffer to remove unbound and non-specifically bound proteins and further 
washed 3 times (30 mL) with PreScission Protease Cleavage Buffer. The GST-SidM and -
Rab1A fusion proteins were proteolytically cleaved by adding PreScission protease and 
incubating the GS at 4 °C overnight. SidM and Rab1A proteins were eluted from the GS 
beads using 60 mL PreScission Protease Cleavage Buffer.  
 
Ni-NTA affinity chromatography 
Ni-NTA agarose beads are used for the purification of recombinant proteins with so-called 
His6-tags. Histidine residues of the His6-tag bind to the immobilized nickel ions with high 
specificity and affinity. In this study, Rab1A1-210 and variants thereof were produced as 
fusion proteins bearing a C-terminal His6-tag. Elution fractions of Rab1A from glutathione 
affinity chromatography purification were pooled and coupled to the pre-equilibrated (PBS 
buffer) Ni-NTA agarose beads at 4 °C for 1 h. The flow-through was collected to check for 
the presence of unbound fusion protein followed by extensive washing of beads with PBS. 
The beads harboring the His6-tagged target protein were further washed with10 column 
volumes (CV) wash buffer containing 10 mM imidazole (Table 12) to remove impurities. 
The pure His6-tag protein was eluted with 5 CV of elution buffer containing 250 mM 
imidazole. The efficiency of protein fusion binding, yield of fusion protein and purity were 
analyzed by SDS PAGE. 
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Ion exchange chromatography 
Ion exchange chromatography separates protein samples based on their electrostatic 
properties. In cation exchange chromatography, positively charged protein molecules bind 
to a negatively charged resin and vice versa in anion ion exchange chromatography. Before 
applying the sample, the column was washed with buffer containing a high NaCl 
concentration to displace all other charged species. Washing with a low ionic strength 
buffer then removes all unbound Na+ and Cl- ions. After binding and washing, the bound 
proteins were eluted using a linear NaCl gradient. The binding of the protein to the resin 
depends on the pH of the solvent.  
In this work, Rab1A1-210 and Rab1A1-210/SidM317-545 complex were purified by anion 
exchange chromatography (MonoQ HR 10/100 GL, GE Healthcare) and SidM317-545 by 
cation exchange chromatography (MonoS HR 10/100GL, GE Healthcare). The peak 
fractions were collected and analyzed on the SDS-PAGE for the target protein.  
 
Size exclusion chromatography 
Size exclusion chromatography (SEC) is also referred to as gel permeation 
chromatography or gel filtration. It separates proteins based on their molecular size 
(hydrodynamic volume). Proteins larger than the pores size of the resin material unable to 
enter the porous particles will pass through the space in between the beads and will elute 
first. Smaller molecules will be retained in the porous particles and elute at slower rate. In 
this work, affinity purified Rab1A1-210 and SidM317-545 were mixed and subjected to SEC. 
The peak fractions were collected and analyzed on the SDS-PAGE to analyze the 
formation of Rab1A1-210 /SidM317-545 complex. All the SEC experiments were conducted 
on ÄKTA purifiers with HiLoad Superdex 75 and 200 10/30, 16/60 and 26/60 columns.  
 
2.6 Protein Analytical Methods 
2.6.1 Concentration of Proteins 
Protein samples were concentrated for SEC, Isothermal Titration Calorimetry (ITC) and 
crystallization experiments by ultracentrifugation using Vivaspin 2, 6 and 20 concentrators 
with desired molecular weight cut-offs. The molecular weight cut-off of the concentrators 
was selected at least 10 kDa smaller than the protein. The concentration of purified 
proteins were measured by measuring the absorption at 280 nm (A280) using a Nanodrop 
ND-1000 spectrophotometer (peqLab, Erlangen, Germany) 
34	  	  
 
2.6.2 SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Protein samples were analyzed by sodium dodecyl sulfate (SDS) polyacrylamide gel 
electrophoresis (PAGE). This technique separates proteins based on their molecular 
weight. SDS is a strong anionic detergent that binds non-covalently to proteins disrupting 
their native structure. SDS treated proteins are negatively charged and migrates towards a 
positively charged anode in an electric field. Protein samples were mixed with 8x sample 
buffer (10 µL protein +2 µL sample buffer). Samples were heated at 95 °C for 5 min to 
denature the protein. The protein samples were loaded onto the gel and run at constant 40 
mA for 30-35 min. The gel was stained for 15-20 min in a Coomassie Brilliant Blue R-250 
solution and excess stain was removed by destaining solution. 
 
2.6.3 Surface Plasmon Resonance (SPR) Spectroscopy 
Surface Plasmon Resonance (SPR) is a biosensing technique to measure biomolecular 
interactions in a label free environment. One of the interactants (ligand) is immobilized 
onto the metal film (Gold layer), whereas the second (analyte) is passed over the surface in 
a continuous flowing aqueous solution. Plane polarized light is reflected off the opposite 
side of the metal film. At a certain angle the light excites the electrons in the gold layer 
generating a surface plasmon and resulting in a loss of reflection. Binding of analyte to the 
immobilized ligand increases the refractive index and hence the angle at which absorption 
of energy occurs. This change in angle is relayed in response units (RUs) and is directly 
proportional to the amount of analyte bound to the ligand. In this work, binding studies 
between Rab1A (ligand) and SidM (analyte) were carried out using a Biacore X 
instrument. Different dilutions of Rab1A1-210 were passed over the surface of a Ni-NTA 
sensor chip (20 µL/min flow rate, 25 °C) to immobilize the ligand via its C-terminal His6-
tag until sufficient ligand had bound (corresponding to 200? RU). Thereafter, 1-5 µM 
solutions of SidM 317-545 were passed over the immobilized Rab1A1-210 to allow for binding 
analysis.  
 
2.6.4 Isothermal Titration Calorimetry (ITC) 
Isothermal Titration Calorimetry (ITC) was also employed to analyze the binding affinity 
between Rab1A1-210 and SidM317-545. In this work, ITC experiments were performed using 
an ITC200 Titration Calorimetry System (Microcal, GE Health care). Prior to the 
35	  	  
experiment, both protein samples were subjected to buffer exchange (50 mM HEPES 
pH8.0, 50 mM NaCl) using SEC and concentrated by ultracentrifugation using Vivaspin-
concentrators. All buffers and protein samples were filtered and degassed to avoid air 
bubbles during the experiment. Cells and the syringe of the ITC200 were extensively 
washed with buffer (50 mM HEPES pH 8.0, 50 mM NaCl). 40 µL of the Rab1A1-210 
solution (1000 µM) was filled into the syringe and titrated against 300 µL of the SidM317-
545 solution (100 µM) present in the sample cell. All titrations were performed at 25 °C, 
500 rpm (syringe rotation).  2 µL were injected per cycle with a total of 18 cycles and 4 s 
duration between injections. Data were analyzed by Microcal Origin7 software. The peaks 
obtained after each injection were integrated to calculate the amount of heat absorbed or 
evolved upon complex formation. The binding affinity constant ‘K’, the stoichiometry ‘n’ 
and the binding enthalpy ‘ΔH’ were derived by curve fitting using the single set of 
independent sites model. 
 
2.7 Crystallization 
As part of this project both SidM317-545 alone and the complex between SidM317-545 and 
Rab1A1-175 were crystallized. Methods used were sitting-drop and hanging drop vapor 
diffusion. Preliminary crystallization trials were carried out using a range of commercial 
screens (Hampton Research and QIAGEN) in Low Profile Greiner 96 well plates by sitting 
drop vapor diffusion setup. The reservoir consisted of 80 µL of the screening solution. 
Crystallization drops were prepared by mixing 200 nL of protein and 200 nL of reservoir 
solution by Mosquito robot (TTP Labtech Ltd). The crystallization plates were sealed with 
crystal clear tape and stored at 4 °C, 10 °C and/or 16 °C. 
Once suitable starting conditions had been identified, protein crystals were optimized in 
24-well plate formats by hanging drop experiments. The reservoir was filled with 500-
1000 µL of reservoir solution and the crystallization drops prepared by mixing 1-2 µL of 
protein solution with 1-2 µL of reservoir solution.  The crystallization drop was pipetted 
onto a siliconised cover slip and inverted over the reservoir with drop facing downwards.  
Silicone grease was applied to the raised rim of the reservoir to seal each experiment. 
Parameters that were optimized to improve crystal quality include the protein 
concentration, precipitant and salt concentrations, the pH of the buffer produce well 
diffracting crystals. 
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2.8 X-ray Data Collection  
Protein crystals were individually harvested from their mother liquor using a nylon loop, 
transferred to a suitable cryoprotectant derived from the mother liquor and flash cooled in 
liquid nitrogen. X-ray diffraction data were collected on a home source comprising a 
rotating copper anode generator and using a Saturn 944HG charged coupled device (CCD) 
detector (Rigaku) as well as at the beam line Proxima1-Soleil. 
 
2.9  Data Processing and Structure Solution 
X-ray diffraction data of SidM317-545 crystals were processed with XDS and scaled with 
XSCALE (Kabsch 1993), those for Rab1A1-175/SidM317-545 complex HKL-Suite 3000 
(Otwinowski and Minor 1997). Further processing of data was carried out using the CCP4 
Suite (Collaborative Computational Project 4, 1994).  Intensities were converted to 
structure factor amplitudes using TRUNCATE from CCP4 package. The structure of the 
Rab1A1-175/SidM317-545 complex was solved by molecular replacement using the structure 
of the complex DrrA340-533/Rab1b3-174 as a search model in Phaser (Storoni, McCoy et al. 
2004).  The model from Phaser was refined using restrained refinement in REFMAC5 
(Murshudov, Vagin et al. 1997). The model was adjusted manually using COOT (Emsley 
and Cowtan 2004). The final structure was validated using Molprobity. Protein figures 
were prepared using PYMOL (http://pymol.sourceforge.net/). 
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3 Results 
In this study, full-length and six C-terminally truncated variants of human Rab1A GTPase as well 
as the central domain of SidM (residues 317-545), a type IVB effector protein from Legionella 
pneumophila, were studied. The genes of interest were cloned into the expression vector pGEX-
6P1 and proteins were produced in E. coli and purified by affinity, ion exchange and size 
exclusion chromatography. The crystal structure of Rab1A1-175/SidM317-545 complex was solved by 
X-ray crystallography and refined to 2.05 Å resolution. 
 
3.1 Human Rab1A, a small GTpase 
cDNA for Human Rab1A was provided by Dr. Matthias P. Machner (National Institute of Child 
Health and Human Development [NICHD], Washington DC, USA. This was transferred to the 
expression vector pGEX-6P1 (GE Healthcare) coding for an N-terminal GST tag by Ms. Christin 
Holland (HZI, Braunschweig, Germany) for expression in E. coli. As part of this thesis, a C-
terminal His6-tag was added to Rab1A by site-directed mutagenesis (section 2.4.4) to allow 
purification of C-terminally intact protein by Ni-NTA affinity chromatography.  
 
3.1.1 Production and purification of recombinant Rab1A 
For simplicity, the GST and His6-tagged full-length Rab1A will hereafter be referred to as Rab1A. 
Rab1A was produced in Rosetta 2 E. coli cells overnight at 20 °C following induction with 0.1 
mM IPTG. Cells were pelleted, lysed by homogenizer and centrifuged to separate soluble and 
insoluble fractions. The soluble fraction was applied to glutathione agarose resin and unbound 
proteins were removed by washing the resin with PBS buffer. The GST fusion tag was cleaved off 
by adding PreScission protease at 4 °C and incubating overnight. The GST free Rab1A was eluted 
using PreScission protease cleavage buffer, while GST remained on the column. The yield and 
purity of the protein were qualitatively analyzed by SDS-PAGE (Fig 3.1). After GST affinity 
purification, Rab1A was observed to degrade rapidly. This was visualized by SDS-PAGE (Fig 
3.1), where Rab1A runs at 23 kDa and degraded product is around 20 kDa. Degradation of Rab1A 
was assumed to be caused by secreted bacterial host proteases. Prior to purification “Complete” 
protease inhibitor cocktail tablets, EDTA-free (Roche) were added to all the buffers to avoid 
degradation. This, however, did not improve the stability of Rab1A. 
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Figure 3.1: Purification of Rab1A by Glutathione affinity chromatography. Coomassie stained SDS-PAGE 
analysis of GST-Rab1A purification. Lanes from left to right, 1-GST fusion Rab1A, 2-Overnight proteolytic cleavage 
of GST fusion Rab1Awith PreScission protease, 3 and 4- Elution fractions of Rab1A (Upper band), degradation 
product of Rab1A (Lower band) 
 
3.1.2 C-terminal deletions of Rab1A 
To stabilize Rab1A, 5, 15, 18, 23 and 35 amino acid residues were C-terminally deleted by site-
directed mutagenesis using primers designed to retain the His6-tag - except in the case of Rab1A 1-
175 (Fig 3.2).  The resulting Rab1A variants were all produced and purified as for full-length 
Rab1A. Variants Rab1A1-205, Rab1A1-195 and Rab1A1-187 similarly prone to degradation as the full-
length protein (Fig 3.3).  
Rab1A is 23 kDa
GST-Rab1A  49 kDa
GST 26 kDa
Degradation product
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Figure 3.2: C-terminal deletions of Rab1A. Rab1A was C-terminally truncated by site-directed 
mutagenesis. The C-terminal His6-tag was retained for all variants except Rab1A1-175. 
 
 
His6 -tagRab1A 1 -195
His6 -tagRab1A 1 -192
His6-tagRab1A 1-187
Rab1A 1-175
Rab1A 1 -210 His6 -tag
Rab1A 1 -205 His6 -tag
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Figure 3.3: Coomassie stained SDS gel showing the instability of Rab1A1-187 variant. Lanes from left to right, 1. 
Protein Marker, 2. GST Rab1A1-187 fusion protein, 3. Overnight cleavage of GST fusion Rab1A1-187 with PreScission 
protease, 4. and 5. Elution fractions of Rab1A1-187. Degradation of variant Rab1A1-187 is indicated by a red rectangular 
box. 
 
3.1.3 Production and purification of stable Rab1A1-175 
As outlined above, a range of C-terminal deletions of Rab1A still resulted in unstable protein. 
Hence, Rab1A was further C-terminally deleted by adding a stop codon prior to residue 35 by site-
directed mutagenesis losing the His6-tag in the process. Purification of Rab1A1-175 was as 
described for full-length Rab1A.  Rab1A1-175 did not show any signs of degradation after GST 
affinity purification (Fig 3.4A). Rab1A1-175 eluted as a single peak during size exclusion 
chromatography (SEC) using a Superdex 75 16/60 SEC column with an elution volume of 77 mL 
(Fig 3.4B). Relative to standards the elution volume of Rab1A1-175 corresponds to a molecular 
weight of 20 kDa confirming Rab1A to be monomeric.  
 
Degradation product
Rab1A 1-187
GST
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Figure 3.4 Purification profile of Rab1A1-175 (A) Coomassie stained SDS-PAGE analysis of glutathione affinity 
purified Rab1A1-175. Lanes from left to right, 1. GST-Rab1A1-175 fusion protein; 2. Overnight proteolytic cleavage of 
the fusion protein with PreScision protease; 3, 4. and 5. In consecutive elution fractions Rab1A1-175 appears as a single 
band. (B) SEC elution profile and corresponding SDS gel of Rab1A1-175. Fractions highlighted by red bar on the SDS 
gel show pure and stable Rab1A1-175. 
 
3.2 Type IVB effector protein SidM of Legionella pneumophila 
3.2.1 Production and Purification of SidM317-545 
To analyze the interaction of human Rab1A with SidM from L. pneumophila, the central domain 
corresponding to residues 317-545 of SidM was cloned into vector pGEX-6P1. A GST-SidM317-545 
fusion protein was hence produced in BL21 E. coli cells overnight at 37 ºC induced with 0.1 mM 
IPTG. Cells were harvested, lysed by homogenizer and centrifuged to separate soluble and 
insoluble fractions. The soluble fraction was applied to glutathione agarose resin, unbound 
proteins washed off and GST-fusion protein cleaved on column with PreScission protease 
overnight at 4 ºC. SDS-PAGE analysis of SidM317-545 indicated a stable, undegraded protein (Fig 
3.5).  SidM317-545 was further purified by size exclusion chromatography on a Superdex 75 16/60 
column. See Figure 6 for the elution profile and SDS-PAGE analysis. The first two peaks, marked 
by red and green bars, contain SidM317-545 co-eluting with impurities while the third peak (blue 
bar) contains pure SidM317-545 with an elution volume of 72 mL. Compared to protein standards 
this volume indicates molecular weight of 27 kDa for SidM317-545, which matches its size on SDS-
PAGE gel (Fig 3.6). SidM317-545 was concentrated by ultrafiltration to 13 mg/mL for crystallization 
trials. 
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Figure 3.5: Production and purification of SidM317-545. Coomassie stained SDS-PAGE profile of affinity 
purification of GST-SidM317-545 affinity purification. Lanes from left to right, 1. Protein Marker, 2. Soluble fraction, 
3. Insoluble fraction, 4. Flow through, 5 to 8 elution of unspecifically bound proteins with 1xPBS, 9. GST fusion 
SidM, 10. Cleavage of GST–fusion protein with PreScission protease, 11 and 12. Elution of SidM 
 
 
 
 
Figure 3.6: Size exclusion chromatography of SidM317-545. Coomassie stained SDS-PAGE gel and chromatogram of 
27kDa SidM
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size exclusion chromatography of SidM317-545 using a Superdex 75 16/60 column. Peaks one and two, marked by red 
and green bars contain SidM317-545 with other impurities whereas peak 3 indicated by blue bar (elution volume of 72 
mL) contains pure SidM317-545. Fractions containing pure SidM317-545 were pooled and concentrated by Vivaspin. The 
corresponding SDS-PAGE gel is featured as the right-hand insert. 
 
3.2.3 Crystallization of SidM317-545 
After final purification of SidM317-545 by SEC, the protein was concentrated by ultrafiltration to 15 
mg/mL for crystallization. Initial screening for crystallization lead conditions was performed in 96 
well plate by sitting drop vapor diffusion. Around a thousand crystallization conditions were 
screened at both 10 and 16 °C and various protein concentrations. SidM317-545 crystals were 
observed in a condition containing 0.1 M phosphate citrate buffer pH 4.25, 5 % PEG 3000, 12 % 
1, 2-propanediol and 10 % glycerol at 16 °C (Fig 3.7A). However, the resultant crystals were in 
clusters unsuited for single-crystal diffraction experiments. These initial crystals were used to 
prepare crystallization seeds in crystal optimization trials. Conditions were optimized by varying 
pH, PEG and protein concentrations, finally yielding individual large crystals (Fig 3.7B). These 
crystals diffracted X-rays to ~ 3 Å at the Soleil synchrotron (Fig 3.8) and also on an in-house 
rotating anode generator (Rigaku MicroMax 007 HF) equipped with a CCD detector (Rigaku 
Saturn944HG). The diffraction data was processed using MOSFLM (Leslie and Powell 2007). 
Closer inspection of the diffraction pattern indicated SidM317-545 crystals to have a modulated 
structure, meaning the fundamental unit cell can be obtained using strong reflections only. 
Indexing of these reflections results in a primitive triclinic basis cell with a = 60 Å, b = 151 Å, c = 
153 Å, α = 98 °, β = 101 ° and γ = 101 °. These parameters can be transformed to a body centered 
orthorhombic lattice with unit cell dimensions a = 60 Å, b = 191 Å, c = 229 Å when incorporating 
the weaker diffraction spots along C-axis. These satellite reflections are represented by 
incommensurate vector q (personal communication: Dr. Toine Schreurs, BIJVOET Centre for 
Biomolecular Research, Utrecht University, Utrecht, The Netherlands). Processing of diffraction 
data with this larger unit cell resulted in a completeness of 30 %, insufficient for structural 
analysis. Optimization experiments with detergent and additive screens failed to solve the 
incommensurate crystal problem.  
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Figure 3.7: Crystallization of SidM317-545: A) An initial sitting drop vapor diffusion screen yielded small clustered 
crystals. B) Micro-seeding using initial crystals as seeds by hanging drop method resulted in plate-like large crystals 
that diffracted to 3.0 Aº.] 
 
Figure 3.8: A diffraction image of SidM317-545 crystal. The blue circle indicates the resolution limit of 3.0 Å  
 
 
 
3.3 Complex formation of SidM317-545 /Rab1A1-175 
3.3.1 Purification and analysis of SidM317-545 /Rab1A1-175 complex 
 
SidM of L. pneumophila was previously shown to interact with the human, small GTPase Rab1A 
(Machner et al, 2007). Structural information for Rab1A was available while the structure of SidM 
A B 
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was unknown. To understand the structural details of the SidM interaction with Rab1A, the central 
domain of SidM (residues 317-545) was complexed with Rab1A (Fig 3.9). SidM and Rab1A were 
purified separately by glutathione agarose affinity chromatography (See chapter 2.3.3). Fractions 
of both proteins eluted following cleavage from GST were analyzed by SDS-PAGE (Fig 3.9A). 
SidM317-545 and Rab1A1-175 were mixed and incubated at 4 °C to allow complex formation. The 
resulting Rab1A1-175/SidM317-545 complex was purified by Size Exclusion Chromatography to 
remove impurities and uncomplexed proteins, and also to establish whether dissociation of the 
complex occurs. Fig 3.9B combines the chromatogram and SDS-PAGE. As expected, the complex 
eluted first (highlighted by a red bar, ~47 kDa) followed by excess SidM317-545 (magenta bar). 
Clearly Rab1A1-175 and SidM317-545 form a tight, 1:1 complex (Fig 3.9B) 
 
 
 
 
 
Figure 3.9: Purification profile of SidM/Rab1A complex 
(A) Glutathione affinity purification of SidM and Rab1A. Elution fraction of SidM and Rab1A were analyzed by 
SDS-APGE. (B) Size exclusion chromatography of SidM/Rab1A complex. Coomassie stained SDS-PAGE gel and 
chromatogram showing the formation of complex, fractions highlighted in red bar indicates SidM/Rab1a complex 
eluted with an elution volume of 64 mL corresponds to 47 kDa and fractions highlighted in magenta bar indicates 
excess SidM 
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3.3.2 Stability of SidM317-545 /Rab1A1-175 complex 
 
The SidM317-545/Rab1A1-175 complex was further purified by anion exchange chromatography 
(AEC). In addition this method would further establish the tightness of the complex. The pH was 
chosen to allow excess SidM317-545 to elute in the flow through rather than binding to the column 
while the complex did bind and was thereafter eluted using a linear NaCl gradient. The AEC 
chromatogram (Fig 3.10) reveals a single elution peak, which SDS PAGE analysis confirmed to 
correspond to homogenous Rab1A1-175/SidM317-545 complex. Thereafter the Rab1A1-175/SidM317-545 
complex was further purified by SEC to remove excess NaCl prior to crystallization. 
 
 
 
 
Figure 3.10: Anion exchange chromatography of SidM317-545 /Rab1A1-175complex 
Separation of excess SidM317-545 fromSidM317-545 /Rab1A1-175 complex. SidM317-545 /Rab1A1-175 complex was applied to 
the anion exchanger and eluted by salt gradient from 0 to 100mM NaCl. Unbound SidM317-545 came out in the flow 
through indicated by red bar and elution fractions of SidM317-545 /Rab1A1-175 complex were indicated by green bar. 
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3.3.3 Co-expression of SidM317-545 and Rab1A1-175 
 
To speed up purification of SidM317-545/Rab1A1-175 the two proteins were co-expressed in E. coli 
BL21 and Rosetta 2 to allow stable complex formation in situ. For this, the gene encoding 
SidM317-545 was cloned into the vector pETM-30 by a restriction free cloning (see section 2.4.5 for 
details on the method). For Rab1A1-175 production the existing pGEX-6P1 (Fig 3.11A & B). As the 
vector pETM-30 carries kanamycin and pGEX-6P1 ampicillin antibiotic resistance genes, 
retention of both plasmids can be enforced by adding both antibiotics. Co-expressed SidM317-
545/Rab1A1-175 complex was purified by GST affinity chromatography followed by SEC.  
Production of soluble SidM317-545 and Rab1A1-175 was analyzed on SDS-PAGE (Fig 12A). SidM317-
545 and Rab1A1-175 co-eluted from the glutathione agarose column. SidM317-545 was, however, 
markedly more strongly produced than Rab1A1-175 (Fig 3.12A). Fractions containing the complex 
were pooled and further purified by SEC. 
 
 
 
Figure 3.11: Co-expression of SidM317-545 and Rab1A1-175. (A) Re-cloning of sidM in to pETM-30 vector. (B) Co-
expression of pGEX-6P1Rab1A1-175 and pETM-30 SidM317-545 into Rosetta 2.E. coli cells 
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Figure 3.12: Co-expression and purification profile of SidM317-545/Rab1A1-175 
(A) Coomassie stained SDS-PAGE showing glutathione agarose affinity purification profile of SidM317-545 /Rab1A1-
175, where Rab1A is co-eluted with SidM. (B) Coomassie stained SDS-PAGE of SEC of SidM317-545 /Rab1A1-175. 
Fractions highlighted by the red rectangle contain SidM317-545 /Rab1A1-175 (C) SDS-PAGE showing concentrated 
SidM317-545 /Rab1A1-175 after SEC. 
 
 
3.4 Surface Mutagenesis of Rab1A 
 
3.4.1 Rab1AK55S-K58S and Rab1AE168A-K170S-K171A-R172S variants 
Following numerous failed attempts to crystallize the SidM317-545/Rab1A1-175 complex, the method of 
entropy reduction was used on Rab1A to increase the likelihood of crystallization. Long, flexible 
surface residues such as lysine and arginine were replaced by short, less flexible alanines and 
serines. Two variants of Rab1A were constructed by site-directed mutagenesis: the double variant 
K55A-K58S and the quadruple variant E168A-K170S-K171A-R172S. Production and purification 
of the variants were carried out as for full length Rab1A. However, neither of these variants 
resulted in crystals. Coincidentally though SEC (Fig 3.13) and ITC experiments (Fig 3.24) 
demonstrated the variant Rab1AK55A-K58S to be strongly impaired for SidM317-545 binding compared 
to wild type Rab1A.  
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Figure 3.13: SEC purification profile of Rab1AK55A-K58S/SidM317-545. Rab1AK55A-K58S and SidM317-545 are largely 
separated during SEC purification. Fractions of the first SEC peak highlighted by the red bar contain SidM317-545 
together with larger impurities. The green bar marks SidM317-545 with a small amount of retained Rab1AK55A-K58S. The 
pink bar highlights fractions of the third peak essentially containing unbound Rab1AK55A-K58S.  
 
 
 
3.5 Structure of SidM317-545 /Rab1A1-175 complex 
 
3.5.1 Crystallization of SidM317-545 /Rab1A1-175 
 
As part of this thesis, six truncation variants of human Rab1Awere generated. Each was screened 
over a wide variety of conditions to generate crystals in complex with SidM317-545 with the aim of 
solving the crystal structure of the complex. All truncation mutants tightly bind SidM317-545. 
However only the complex consisting of SidM317-545 and Rab1A1-175 and where both genes were 
co-expressed in E. coli was successfully crystallized. The SidM317-545 /Rab1A1-175 complex was 
concentrated to 15 mg/mL and crystallization lead conditions were screened for using commercial 
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screens by sitting drop vapor diffusion experiments in 96 well plates. Crystals of SidM317-545 
/Rab1A1-175 complex were finally observed to grow in wells containing 27.5 % PEG 400 and 0.1 
M sodium citrate pH 5.3 at 10 °C (Fig 3.14A). These clustered crystals were optimized by varying 
the pH and precipitant concentrations in a 26 (6x4) well hanging drop vapor diffusion 
crystallization plate. Optimization finally resulted in large single crystals in 35 % PEG 400 and 0.1 
M sodium citrate pH 5.5 (Fig 3.14B). As the reservoir solution already had the properties of a 
cryo-protectant, crystals were directly harvested from the drops, cryo-cooled and subjected to X-
ray analysis. 
 
 
 
Figure 3.14: Crystals of the SidM317-545 /Rab1A1-175 Complex 
 (A) Initial, slightly intergrown crystals of SidM317-545/Rab1A1-175. (B) Optimized SidM317-545/Rab1A1-175 crystals 
grown in a hanging drop experiment yielded a single crystal of sufficient size for X-ray diffraction experiments. 
 
 
3.5.2 Data collection and processing 
 
X-ray diffraction data for SidM317-545 /Rab1A1-175crystals were collected in-house on a rotating 
anode generator (Rigaku MicroMax-007HF) and CCD detector (Rigaku Saturn944HG). The 
diffraction data were indexed, integrated and scaled using the software package HKL3000 
(Otwinowski and Minor 1997). The crystals diffracted X-rays to 2.05 Å resolution and crystals 
were found to belong to the trigonal space group R3 with unit cell dimensions a=b=105.0 Å and 
51	  	  
c=118.6 Å α = β = 90° and γ = 120°.Matthews’s coefficient analysis (Matthews 1968) suggested a 
packing parameter VM = 2.68 Å3/Da corresponding to a solvent content of 54%. This in turn 
implieda crystal packing with of oneSidM/Rab1A dimer per asymmetric unit. 
Structure factors were phased by molecular replacement usingthe programme PHASER (Storoni, 
McCoy et al. 2004) and the complex of DrrA340-533/Rab1b3-174 as a search model. The single 
solution from PHASER was refined by restrained refinement protocol in REFMAC5 (Murshudov, 
Vagin et al. 1997) alternated cyclically with manual adjustment of the model addition of water 
moleculesin COOT (Emsley and Cowtan 2004). This procedure gradually improved the model 
resulting in a final model with R and Rfree values of 16.0 and 19.0 % respectively.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15: Electron density map of the SidM317-545 /Rab1A1-175 Complex after final refinement of the structure. 
The P-loop of Rab1A is depicted in magenta, SidM in cyan. 
 
 
3.5.3 Structure of Rab1A1-175  
 
Structurally Rab1A shares structural features with other small GTPases (See chapter 4.2) such as 
the Switch I and Switch II motifs as well as the P-loop. Rab1A1-175 displays mixed α-helical and β-
sheet structure: a central 6-stranded β-sheet comprised of five parallel (β1R, β3R, β4R, β5R and β6R 
– where the subscript R stands for Rab1A) and one anti-parallel β-strand (β2R) is surrounded by 6 
α-helices (α1R to α6R). The ten connecting loops L1 to L10 are correspondingly denoted β1R-α1R, 
α1R-α2R, α2R-β2R, etc. Five N-terminal residues of Rab1A1-175 are remnants of the PreScision 
protease cleavage site. Part of the loop between β6R and α6R is disordered (Figure 3.16). Structural 
Rab1A SidM 
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elements contributing to switch I (blue in Figure 3.16) include L2, α2R and L3 (residues 34 to 45). 
Switch II (red in Figure 3.16) is comprised of L5, α3R and L6 (residues 63 to 80) .The P-loop 
(magenta in Figure 3.16) is located in L1 spanning residues 16 and 17.  
 
 
 
 
 
 
Figure 3.16: Structure of Rab1A1-175  
Rab1 is shown in green, Switch I domain is represented in blue, Switch II in red, P-loop in magenta and inter switch 
regions in salmon. 
 
 
In the crystal structure of the SidM317-545 /Rab1A1-175 complex, Rab1A1-175 displays mixed α-helical 
and β-sheet structure: a central 6-stranded β-sheet comprised of five parallel (β1R, β3R, β4R, β5R 
and β6R – where the subscript R stands for Rab1A) and one anti-parallel β-strand (β2R) is 
surrounded by 6 α-helices (α1R to α6R). The ten connecting loops L1 to L10 are correspondingly 
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denoted β1R-α1R, α1R-α2R, α2R-β2R, etc. Five N-terminal residues of Rab1A1-175 are remnants of 
the PreScision protease cleavage site. Part of the loop between β6R and α6R is disordered (Fig 3. 
16A&B). Structurally Rab1A shares structural features with other small GTPases (See section 4.2) 
such as the Switch I and Switch II motifs as well as the P-loop. Structural elements contributing to 
switch I include L2, α2R and L3 residues 34 to 45. Switch II is comprised of L5, α3R and L6 
residues 63 to 80.The P-loop is located in L1 spanning residues 16 and 17.  
 
3.5.3 Structure of SidM317-545  
 
SidM317-545 has a unique structural fold and is a purely α-helical structure comprising eight α-
helices (denoted α1S toα8S, where “subscript S” indicates the component SidM). The α-helices are 
connected by seven loops denoted LA to LG corresponding to α1S-α2S, α2S-α3S, α3S-α4S etc. 
SidM317-545 forms a two-layered structure, in which two parallel α-helices α4S and α5S constitute 
the upper layer. This layer coincidentally is the primary contact surface for Rab1A. The lower 
layer is formed by the roughly parallel α-helices α1S, α2S, α6S and α7S. The two α-helical layers are 
oriented at an angle of 90 ° to each other. The other two small helices α3S and α8S are located at 
the end of α4S and α5S respectively (Figure 3.17). 
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Figure 3.17: Structure of SidM317-545 rendered in cyan, helices indicated by numbers 
 
 
3.5.4 The SidM317-545 /Rab1A1-175 Complex 
SidM and Rab1A form a stoichiometric complex in which SidM binds predominantly to the 
Switch I, Switch II and P-loop regions of Rab1A (Figure 3.18).  SidM binding induces 
conformational changes on Rab1A structure, where Switch I is displaced away from the nucleotide 
binding site and Switch II adopts ordered conformation (Detail explanation in section 4.2).  
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Figure 3.18:  The Crystal Structure of the SidM317-545 /Rab1A1-175 Complex. Cartoon representation of the SidM317-
545/Rab1A1-175 complex. SidM317-545 interacts with the Switch I, Switch II and P-loop of Rab1A1-175. Rab1A1-175 is 
represented in green, with Switch I in blue, Switch II in red, the P-loop in magenta and SidM317-545 in cyan. The black 
dashed line in the Rab11-175 structure indicates the disordered loop.   
 
 
3.5.5 Interface of the SidM317-545 /Rab1A1-175 Complex 
In the crystal structure of the complex, the interactions between the SidM317-545 and Rab1A1-175 
bury surface accessible area of 1816Å as calculated by the PISA server (Krissinel and Henrick, 
2007). Structural elements involved in complex formation are the N-terminal loop, β1R, β2R, 
Switch I, Switch II and P-loop of Rab1A1-175 and the α2S, α4S, α5S, α6S and α8S helices and the 
loops LD, LE, LF of SidM317-545 (Figure 3.19).  
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Figure 3.19: Surface representation of the SidM317-545 /Rab1A1-175 Complex. (A) Rab1A and SidM are shown in 
surface representation.  Switch I of Rab1A is shown in blue, Switch II in red, P-loop in magenta and other regions in 
green and SidM in cyan (B) The Rab1A interacting region of SidM is shown in surface representation and Rab1A is in 
cartoon presentation 
Based on the contact regions of Rab1A1-175, the interactions of the complex can be divided in to 
four sections 
 
3.5.6 Switch I of Rab1A1-175 contacts α2, α5, α6 and LF of SidM317-545 
 
In the crystal structure of SidM317-545/Rab1A1-175 complex, the larger part of the switch I region of 
Rab1A (residues 34 to 48) as well as L2 (α1R-α2R), α2R and L3 (α2R-β2R) contact the upper layer 
α5S and the bottom layer α2S, α6S and LF (α6S-α7S) of SidM (Figure 3.18). 
 
Figure 3.20: Interactions between Rab1A Switch I and SidM. (A) Hydrogen bond interactions between Switch I of 
Rab1A and SidM. Rab1A residues are represented in green, those of SidM in black. Hydrogen bonds are represented 
by black dotted lines. (B) Hydrophobic interactions between Switch I of Rab1A and SidM. Grey lines indicate 
hydrophobic interactions. 
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Contacts include several hydrogen bonds and hydrophobic interactions. Loop L2 (α1R-α2R) 
residues T34R (O), E35R (Oε1, Oε2) and S36R (N, Oγ) of Rab1A form strong direct and water-
mediated hydrogen bond interactions with LF (α6S-α7S) residues D480S (N) and S483S (Oγ) of 
SidM Fig (3.20A). The α2R and L3 of Rab1A bears several hydrophobic residues Y37R, I38R, 
I41R, V43R and F45R, which makes extensive hydrophobic interactions with α5S and α6S residues 
A345S, V436S, M439S, F474S and V478S of SidM (Fig 3.20B). The structural changes in the 
Switch I region of Rab1A, upon SidM binding is discussed in detail in section 4.2  
 
 
3.5.7 Switch II contacts of Rab1A1-175with SidM317-545 
 
 
Figure 3.21: Interactions between Rab1A Switch II and SidM. (A) Hydrogen bonding interactions of Switch II of 
Rab1A and SidM. Rab1A residues are represented in Green and SidM residues in Black respectively. Hydrogen bonds 
are represented in black dotted lines. (B) Hydrophobic interactions between Switch II of Rab1A and SidM. Grey lines 
indicate hydrophobic interactions. 
 
The structural elements L5, α3R and L6 of Rab1A Switch II (residues 63-80) extensively interact 
with α4S, α5S, α8S and LE of SidM through hydrogen bonds and hydrophobic interactions (Fig 
A
B
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3.21A&B). Helix α3R of Rab1A form strong interactions with LE and α5S of SidM through several 
hydrogen bonds between negatively charged Q68R of Rab1A with N451S (N) and R453S (NH1) of 
SidM.  In addition, positively charged R69R of Rab1A interacts strongly with A441S, D445S, 
L448S, S449S, A454S and Q452S of SidM through several direct and water mediated hydrogen 
bonds (Fig 3.21A). Apart from these hydrogen-bonding interactions, L6 and α4R of Rab1A also 
interact with α4S, α5S and LE of SidM through hydrophobic interactions. F70R of Rab1A forms 
multiple hydrophobic interactions with L406S, W410S, M444S and A454S of SidM, where   W410S 
forms aromatic π-stacking interaction with F70R (Fig 3.21B).  
 
 
3.5.8 P-Loop and other contacts of Rab1A1-175 with SidM317-545 
 
Phosphate binding loop L1 of Rab1A (residues D16 and S17) contacts LE of SidM through a salt 
bridge (D16R Oδ1/Oδ2 to R453S Nζ1/Nζ2) and two hydrogen bonds (S17R N/O to N451S 
Nδ2/Oδ1) (Fig 3.22). 
 
 
Figure 3.22: P-loop interactions of Rab1A1-175 with SidM317-545. P-loop residues of Rab1A are coloured magenta, 
SidM residues cyan. Hydrogen bonds are indicated by black dotted line. 
 
 
Apart from the Switch I, II and P-loop of Rab1A, other regions are also involved in the interaction 
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with SidM (Fig 3.23). Thus the N-terminus of Rab1A contacts LD of SidM through hydrogen 
bonds (N2R N ··· L423S O; N2R Nδ2 ··· T424S O; Y5R Oζ··· T422S O; Y5R Oζ ··· S426S Oγ; K10R 
Nζ···A421S O and R418S O; Fig 23A) and hydrophobic interactions (L8R = A421S and Y5R = 
L423S; Fig 3.23B). Similarly, L2R hydrogen bonds LD (D31R Oδ2 ··· T427S Oγ; D31R Oδ2 ··· 
T427S O; and Y33R O ··· S426S O [water mediated]) while β3R interact with α5S (K58R NZ ··· 
S426S Oγ and Q60R Nε2 ···S426SO [water mediated]). 
 
 
 
 
 
Figure 3.23: Other interactions between Rab1A and SidM. (A) Hydrogen bonding interactions of Rab1A and 
SidM. Rab1A residues are represented in green and SidM residues in black. Hydrogen bonds are represented by black 
dotted lines. (B) Hydrophobic interactions between Rab1A and SidM. Grey dashed-dotted lines indicate hydrophobic 
interactions. 
 
 
 
3.6 Isothermal Titration Calorimetry (ITC) Measurements 
The affinity of SidM317-545 for Rab1A1-175 was analyzed and quantified by Isothermal Titration 
Calorimetry (ITC) to complement earlier qualitative analyses by size exclusion chromatography 
(SEC). ITC is particularly sensitive and powerful in that it provides all the binding parameters 
such as binding affinity (K), binding stoichiometry (n), and binding enthalpy (ΔH) in a single 
experiment. 
ITC experiments were performed on a Microcal ITC-200. Data is processed and evaluated using 
Microcal software integrated in Origin 7. SidM317-545, and Rab1A (full length and variants) were 
purified and final buffer exchange was performed with 50 mM HEPES (pH 8.0) and 150 mM 
NaCl using a Superdex 75 1030 SEC column. The protein samples were concentrated to 100-1000 
A B
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µM by vivaspin ultra centrifugal filter units of 10kDa molecular weight cut off and degassed for 
10 minutes prior to any experiment.  
In this experimental approach two states of Rab1A were used for the interaction analysis with 
SidM317-545: In the first state, Rab1A: GDP was titrated to SidM317-545. In the second state Rab1A: 
GDP was treated with 20 mM EDTA during all the purification steps to chelate Mg2+ and remove 
GDP. 
 
 
 
3.6.1 State A- Rab1A: GDP/SidM317-545 
The binding affinity of Rab1A: GDP to SidM317-545 was analyzed by titrating 18 x 2 µL injections 
of 1000 µM Rab1A: GDP from the syringe into the calorimetric cell containing 300 µL of 100 µM 
SidM317-545 at 25 ºC. Fig 3.24A shows the ITC titration curves of Rab1A: GDP to SidM317-545. 
Each peak from the upper panel, in pointing upwards, represents the amount of heat absorbed 
upon binding of Rab1A to SidM317-545, indicating the reaction to be endothermic. The lower panel 
plots the integrated heat from each injection against the molar ratio of Rab1A to SidM317-545. The 
binding affinity constant ‘K’, stoichiometry ‘n’ and binding enthalpy were derived by curve fitting 
using a “single set of independent sites” model. Analysis of the ITC data for Rab1A: GDP to 
SidM317-545 generated the dissociation constant Kd of 790nM. Thermodynamic parameters 
obtained from the curve fitting are indicated in Table 3.1 . 
 
3.6.2 State B: EDTA treatment of Rab1A/SidM317-545 
Recent studies have shown that, Rab1 binds SidM317-545 with high affinity in its GDP-free state. In 
this study, Rab1A: GDP was treated with 20 mM EDTA during all the purification steps to chelate 
the Mg2+ and thereby reduces the binding affinity of GDP. In the final purification step, EDTA 
was removed by exchanging the buffer by 50 mM HEPES pH 8.0 and 150 mM NaCl. ITC 
experiments were performed similarly to those for Rab1: GDP (State A) to SidM317-545. 
Interestingly, the binding affinity of SidM317-545 for EDTA-treated Rab1A was two-fold higher 
than Rab1A: GDP:Mg2+ (Fig 3.24B). Again the binding of Rab1A to SidM317-545 is an 
endothermic. In the lower panel the integrated heat from each injection is plotted against the molar 
ratio of Rab1A to SidM317-545. Curve fitting indicates dissociation constant Kd of 420 nM for State 
B EDTA: Rab1A to SidM317-545. Other derived thermodynamic parameters are listed in Table 3.1. 
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Figure 3.24: Isothermal titration curves of Rab1A: GDP/SidM and EDTA+Rab1A/SidM 
(A) The titration curves of Rab1A: GDP against SidM represents the reaction to be endothermic. The top panel shows 
the raw data produced by titrating 1000 µM of Rab1A: GDP to 100 µM of SidM. The bottom panel represents the 
integration of peaks against the molar ratio of Rab1A: GDP to SidM. (B) The titration curves of EDTA+Rab1A: GDP 
against SidM represents the reaction to be endothermic.  
 
 
3.6.3 Effect of Rab1AK55A-K58S variant on binding affinity with SidM 
 
Prior to solving the structure of the Rab1A1-175/SidM317-545complex, Rab1A was surface 
engineered to facilitate its crystallization. As part of this strategy, surface residues K55 and K58 
were exchanged by A55 and S58 by site-directed mutagenesis. Unexpectedly, SEC analysis 
indicated this variant to have a decreased affinity for SidM (Fig 3.13). The crystal structure of the 
Rab1A1-175/SidM317-545 complex, confirms K58 of Rab1A to contribute to the interaction with 
SidM317-545 (Fig 3.25B). An ITC experiment undertaken to quantify the effect indicated a ten-fold 
decrease in affinity of Rab1AK55A-K58S for SidM compared to the wild-type protein (Fig 3.25 A) 
Thermodynamic binding parameters are listed in Table 3.1.  
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Figure 3.25: Decreased affinity of Rab1AK55A-K58S for SidM317-545 
(A) ITC titration curves of EDTA treated Rab1AK55A-K58S to SidM317-545.The reaction is endothermic. The Top panel 
shows the raw data produced by titrating 1000 µM of Rab1AK55AK58S variant to 100 µM of SidM317-545. The Bottom 
panel represents the integration of above peaks against the molar ratio of Rab1AK55A-K58S to SidM317-545. (B) The 
interaction of K58 of Rab1A (green) with S426 of SidM317-545 (cyan) from the SidM317-545 /Rab1A1-175 crystal 
structure. 
 
3.6.4 Effect of Rab1 variants E35A, Y37A and I41A on binding to SidM 
 
Key residues of Rab1A1-175 involved in the interaction with SidM317-545 were identified from the 
crystal structure of Rab1A1-175/SidM317-545: E35R, Y37R and I41R from the switch I region of 
Rab1A were classified as critical for the interaction with SidM317-545 (Fig 3.20A&B).  These 
residues were replaced by alanines by site-directed mutagenesis and corresponding pure samples 
prepared as described for wild-type Rab1A. The interaction of SidM317-545 with Rab1 variants was 
analyzed by ITC as for wild-type Rab1A. ITC results reveal that all three Rab1A variants E35A, 
Y37A and I41A result in a significant decrease in the affinity towards SidM317-545 (Fig 3.26A&B 
and Fig 3.27). The details of binding affinity are summarized in the Table 3.1. 
 
 
A. EDTA treated Rab1AK55AK58S/SidM (317-545)
K58R
2.8Å
S426S
B. Rab1A K58R contact with S426S of SidM (317-545)   
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Figure 3.26: Isothermal titration curves of EDTA-treated Rab1AY37A and Rab1AI41A/SidM (A) The titration 
curves of EDTA treated Rab1AY37A against SidM represents the reaction to be endothermic. Top panel: raw data from 
titrating 1000 µM Rab1AY37A to 100 µM of SidM. Bottom panel: integrated peaks from upper panel peaks plotted 
against the molar ratio of Rab1AY37A to SidM. (B)The titration curves of EDTA treated Rab1A I41A against SidM 
represents the reaction to be endothermic. Top panel shows the raw data produced by titrating 1000 µM of EDTA 
treated Rab1AI41A to 100 µM of SidM. Bottom panel represents the integration of above peaks against the molar 
ration of Rab1AI41Ato SidM. 
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Figure 3.27: Isothermal titration curves of EDTA treated Rab1AE35A/SidM. The titration curves of EDTA treated 
Rab1AE35A against SidM identifies the reaction to be endothermic. The upper panel shows the raw data produced by 
titrating 1000 µM Rab1AE35A to 100 µM SidM. The bottom panel represents the integration of above peaks against the 
molar ratio of Rab1AE35A to SidM.  
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Table 4.1 Thermodynamic binding parameters forSidM317-545 /Rab1A1-175and Rab1A variants 
 
Thermody
namic 
parameter
s 
Rab1A:GDP/Sid
M317-545 
EDTA:Rab
1A/SidM317-
545 
EDTARab1AK
55A-K58S/SidM317
-545 
EDTA:Rab1A
E35A/SidM317-545 
EDTA:Rab1A
Y37A/SidM317-
545 
EDTA:
Rab1A
I41A/Sid
M317-545 
ka M-1 1.26x106 2.36x106 3.02x104 6.20x105 1.60x105 7.50x
104 
kd(µM) 0.793 0.423 33 1.6 6.25 13 
N 1.19 1.56 1.07 1.5 1.6 1.0 
ΔH 
kcal/mo
l 
4.04 3.6 6.08 5.8 6.7 4.1 
 
 
 
ble 1 
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4 Discussion 
 
4.1 SidM Manipulates Rab1A Function for Legionella pneumophila 
Survival 
Rab1 is a small GTPase that regulates intracellular trafficking between the 
endocytoplasmic reticulum (ER) and the Golgi complex (Plutner, Cox et al. 1991; Tisdale, 
Bourne et al. 1992; Pind, Nuoffer et al. 1994; Wilson, Nuoffer et al. 1994; Somsel Rodman 
and Wandinger-Ness 2000; Moyer, Allan et al. 2001). In common with other GTPases, 
cytosolic Rab1 is normally kept in an inactive state by a dedicated GDP-dissociation 
inhibitor (GDI). To activate Rab1, a GDI-displacement factor (GDF) is required to remove 
the GDI before a GTP exchange factor (GEF) can induce the release of GDP to allow for 
subsequent uptake of GTP and activation of Rab1. SidM is a Type Four Secretion System 
effector protein from L. Pneumophila that has both GEF and GDF activity for 
Rab1GTPase (Machner and Isberg 2006). SidM recruits Rab1 to the Legionella-containing 
vacuole (LCV) as part of generating a specialized vacuole that resembles the host’s rough 
endoplasmic reticulum. Within this vacuole L. pneumophila creates a replication niche 
allowing it to evade destruction by lysosomal fusion (Machner and Isberg 2006; Murata, 
Delprato et al. 2006).  
Prior to the initiation of this study, no structural information for SidM was available. To 
understand the SidM/Rab1 complex at the atomic level, the central domain of SidM317-545 
and Rab1A1-175 were each purified and co-crystallized. Complex formation of SidM/Rab1 
was analysed by SEC and ITC experiments. The structure of the SidM/Rab1A complex 
was determined revealing that the GEF domain of SidM is structurally distinct from known 
eukaryotic GEFs. The structure of the complex further revealed that SidM induces several 
conformational changes in Rab1A to facilitate GDP release. ITC experiments show that 
SidM has a higher affinity for GDP-free Rab1A compared to Rab1:GDP. 
 
4.2 SidM Induces Structural Changes on Rab1A 
To identify SidM-induced rearrangements in Rab1A, Rab1A:GDP (PDB ID 2FOL) was 
superimposed on Rab1A from the Rab1A/SidM complex revealing a root mean square 
difference (RMSD) of 1.84 Å for C-α atoms. Major structural changes involve α1R, P-loop, 
Switch I, Switch II and the β5R-α5R loop regions of Rab1A (Fig 4.1C). 
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4.2.1 Structural mechanism of nucleotide exchange by SidM 
Rab GTPases bind GDP/GTP strongly, and GEFs decrease their binding affinity by 
inducing structural changes on Rab GTPases to catalyse nucleotide release (Schoebel, 
Blankenfeldt et al. 2010). Significant structural changes of Rab1A include the unravelling 
of α1R (residues 25-30) to form an extended loop and the translocation of Switch I away 
from the nucleotide-binding pocket through several hydrophobic and hydrogen bond 
interactions with SidM. The central loop region of switch I (residues 36-41) adopts an α-
helical conformation. Tyr33 and Glu34 in the switch I region bind the guanidine and sugar 
groups of the GDP in the Rab1:GDP structure and are significantly dislocated by about 21 
and 28 Å respectively upon SidM binding. In the Rab:GDP structure, carbonyl oxygen (O) 
of I38 is involved in the interaction with Mg2+ and phosphate via a water molecule, 
whereas in the complex structure I38 is dislocated by about 17.2 Å (Fig 4.1B).  
The P-loop of Rab1A consists of a conserved phosphate and Mg2+ binding motif (Vetter 
and Wittinghofer 2001). Mg2+ are essential for high affinity binding of GDP/GTP to the 
Rab GTPases (Hall and Self 1986). In the structure of Rab1:GDP, Lys21 of the P-loop 
binds the β-phosphate of GDP and Ser22 coordinates the Mg2+. In the SidM/Rab1A 
complex, by contrast, SidM hydrogen bonds Asp16 and Ser17 moving Lys21 and Ser22 of 
the P-loop away from the phosphate and Mg2+-binding sites, reducing the Rab1A affinity 
towards Mg2+ and thereby weakening the binding affinity for GDP.  
In the Rab GTPase:GDP complexes, the switch II region is highly disordered (Eathiraj, 
Pan et al. 2005). In the structure of SidM/Rab1A, switch II is stabilized by multiple 
interactions with SidM. In Rab1:GDP, Asp63 of switch II coordinates Mg2+ via a water 
molecule. In the SidM/Rab1A complex, by contrast Asp63 forms a salt bridge to Lys21 of 
the P-loop thereby abolishing the interaction with Mg2+ and ultimately results in the 
decrease binding affinity of Rab1 for GDP (Fig 4.1B). Other SidM-induced changes 
include shifts of Rab1A loops β2R-β3R by 4.9Å (by the engagement of Lys58) and β5R-
α5R to a position that is occupied by guanosine base in Rab1A: GDP structure. 
The described structural changes of Rab1A brought about by SidM binding combine to 
open the nucleotide binding pocket to release GDP explaining the GEF activity of SidM. 
The SidM mechanism of stabilizing nucleotide-free Rab1A is similar to that of other 
Rab:GEF complexes. 
While our analyses were in progress, two competing groups reported crystal structures of 
Rab1 in complex with GEF domain of SidM (Schoebel, Blankenfeldt et al. 2010; Suh, Lee 
et al. 2010). To compare our SidM/Rab1A complex to the other two, the latter were 
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structurally aligned with our structure. This procedure yielded RMSD values of 0.51 and 
0.59 Å for all C-α atoms of both proteins respectively. The low RMSDs imply essentially 
identical complexes, despite distinct crystal packing arrangements for each. 
Correspondingly, no major conformational changes are observed between these structures. 
Minor structural differences are likely to be caused by the crystal packing arrangement 
(Fig 4.2). 
 
Figure 4.1: SidM-Induced Conformational changes in Rab1A (A). Conformational changes in Rab1A 
induced by SidM are identified by comparing Rab1A from its complex with SidM (green) to Rab1A:GDP 
(grey). Motifs Switch I, Switch II and P-loop are respectively shown in blue, red and magenta. Mg2+and GDP 
are depicted in ball and stick representations. (B). left: Repositioning of Switch I and stabilization of P-loop 
in Rab1A/SidM; right: Mg+2 and GDP binding mode in Rab1A:GDP. (C) Superimposition of Rab1A:GDP 
(grey) and Rab1A from SidM/Rab1A.  
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Figure 4.2: Alignment of SidM/Rab1A structure against other published structures of SidM/Rab1A 
(PDB ID: 2WWX & 3JZA). SidM/Rab1A is represented in green, 2WWX in grey and 3JZA in light blue 
 
 
4.3 SidM affinity for nucleotide-free Rab1A is higher than for 
Rab1A:GDP 
By interacting with the β-and γ-phosphate groups of GDP and GTP, Mg2+ ensures high 
affinity of Rab GTPases for these nucleotides (Hall and Self 1986; Goody, Pai et al. 1992). 
Exogenous EDTA removes Mg2+ from Rab GTPases inducing conformational changes that 
reduce affinity for GDP. GEFs bind nucleotide-free GTPases with higher affinity than 
nucleotide bound GTPases (Lai, Stubbs et al. 1994). In this study, Rab1A:GDP was treated 
with 20 mM EDTA during purification steps to remove Mg2+. Prior to ITC experiments, 
the buffer was exchanged with Mg2+- and EDTA-free buffer. The dissociation constant for 
SidM/Rab1A:GDP was found to be 700 nM (Fig 3.24A). By comparison the affinity of 
SidM for EDTA-treated Rab1A is increased roughly two-fold (KD = 423 nM) (Fig 3.24B) 
confirming that the affinity of SidM for GDP-free Rab1A is higher than for GDP-bound 
Rab1A (Schoebel, Blankenfeldt et al. 2010). However, other studies have quantified the 
KD for the SidM/GDP-free Rab1A to be in the pM range, implying that dissociation of 
GDP from Rab1A in our experiments was incomplete. Nevertheless, we do demonstrate 
that EDTA-induced loss of GDP does affect SidM affinity for Rab1A. 
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4.4 Role of Switch I in SidM binding 
This and previous structural analyses of SidM/Rab1A have revealed that SidM 
predominantly interacts with switch I region of Rab1A dramatically changing its 
conformation. To assess the contribution of individual amino acids, Glu35, Tyr37 and 
Ile41 were substituted by alanine through site directed mutagenesis. Substituting Glu35 by 
alanine eliminates the hydrogen bonds linking Glu35 to Asp480 and Ser483 of SidM (Fig 
3.20). ITC experiments correspondingly indicate that the affinity of SidM for Rab1AE35A is 
decreased ~four-fold relative to wild type Rab1A (Fig 3.27). The affinity of SidM for 
variant Rab1AY37A is reduced ~15 fold (Fig 3.26A) possibly due to the loss of hydrophobic 
interactions with SidM residues Ala435, Phe474, Val478, Met439 and Asn373 (Fig 
3.20B). Similarly, SidM affinity for Rab1AI41A is decreased ~30-fold (Fig 3.24B) probably 
due to the loss of hydrophobic and hydrogen bonding contact with Ala435, Met439, 
His376 and Lys438 of SidM (Fig 3.20A&B). Aligning different Rab sequences reveals that 
switch I residues Glu35, Tyr37 and Ile48 targeted by SidM are not conserved in other Rabs 
(Machner and Isberg 2006). This implies that Rab1A is highly specific for SidM. 
Our site-directed mutagenesis and ITC experiments have shown that other amino acids at 
these positions resulted in decrease binding affinity of SidM for Rab1A.  These findings 
imply that the switch I region is important for SidM binding.  
 
4.4 Comparison of SidM/Rab1A with other GEF/Rab Complexes 
Crystal structures of five eukaryotic GEFs in complex with nucleotide free Rab GTPases 
are currently available:Mss4/Rab8, Vps9/Rab21, Sec2/Sec4, TRAPP/Ypt1 and 
DENN/Rab27 [(Itzen, Pylypenko et al. 2006; Delprato and Lambright 2007; Dong, 
Medkova et al. 2007; Chin, Cai et al. 2009), 2FU5, 2OT3, 2OCY, 3CUE)]. SidM of the 
SidM:Rab1A complex presented in this study, does not share any obvious structural 
similarities with the remaining GEF domains. Nevertheless, the GEF mechanism of SidM 
is related to that of the other GEFs. Most importantly, SidM induces GDP-release 
exclusively through conformational changes in Rab1A, but without directly interacting 
with the nucleotide binding residues as observed in other GEFs.  
Mss4 was shown to have low GEF activity for Rab8 relative to other GEFs. In the crystal 
structure of the nucleotide-free Mss4/Rab8 complex, Mss4 recognizes the switch I and β1- 
β2 inter-switch regions of Rab8 via an intermolecular β-sheet (Itzen, Pylypenko et al. 
2006). Mss4 induces structural changes in switch I and α1 of Rab8, disrupting phosphate 
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and Mg2+ binding regions, opening of the nucleotide binding pocket. The Switch II region 
of Rab8 is not involved in the contact interface, in contrast to other GEF/Rab complexes 
(Fig 4.3).  
In the structure of nucleotide free Rabex-5/Rab21, a helical-bundle Vps9 domain of the 
Rabex-5 catalytic core binds the switch/inter-switch regions and P-loop of Rab21 inducing 
an open conformation of the nucleotide binding pocket. Asp185 of Vps9 interacts with the 
conserved Lys21 from the Rab21 P-loop disrupting the phosphate and Mg2+ binding sites 
and stabilizing the disordered P-loop (Fig 4.3) and the switch II region (Delprato and 
Lambright 2007). 
TRAPP1 is a multimeric membrane tethering complex and acts a GEF for Ypt1 of yeast. In 
contrast to other GEFs, the catalytic core of TRAPP1 is distributed among multiple 
subunits: Trs23p, Bet3p and Bet5p. In the crystal structure of TRAPP1/Ypt1, TRAPPI is 
seen to interact with the N-terminus, β1, Switch I, II and P-loop of Ypt1 (Fig 4.3). The C-
terminus of Bet3p of TRAPP1 interacts with switch I region opening of the nucleotide 
binding pocket and disrupting the phosphate and Mg2+ binding sites to release GDP (Chin, 
Cai et al. 2009). 
Sec2p functions as a GEF for the Rab GTPase Sec4p in yeast. The crystal structure of 
nucleotide free Sec2p/Sec4p revealed that Sec2p exhibits a parallel, homodimeric, coiled 
coil structure. Sec2p interacts with the Switch regions and the P-loop of Sec4p (Dong, 
Medkova et al. 2007; Sato, Fukai et al. 2007). Upon complex formation, Switch I residues 
involved in GDP base and sugar moiety binding undergo positional change, where Ile50 of 
Sec4p is forcibly placed close to the site occupied by Mg2+ in the nucleotide-bound forms. 
In this way, Ile50 disrupts the Mg2+ binding site of the P-loop, thus lowering the Sec4p 
affinity for GDP.  
The GEF domain of SidM interacts with β1, switch I, II and P-loop of Rab1A displacing 
switch I away from the nucleotide binding site, stabilizing the P-loop and disrupting Mg2+ 
and phosphate binding site (Fig 4.2) releasing GDP from Rab1A. 
Comparing the structures of GEF/Rab complexes indicates that Switch I displacement 
(including conserved residues involved in nucleotide binding) invariably induces 
nucleotide release. Similarly, all GEFs are seen to disrupt the Mg2+ and phosphate binding 
sites by inserting disruptive residues or by facilitating conformational changes. And 
finally, Switch II is forced to adopt an ordered conformation by GEFs.  
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Figure 4.3: Comparison of the Crystal structures of different Rab:GEF Complexes. In the Rab: GEF 
complex structures, Rabs are color coded in green and GEF domains are represented in cyan. The structural 
elements of Rab GTPases involved in the interaction are color coded as switch I- blue, switch II- red, inter-
switch region- salmon and P-loop in magenta. Images were drawn by pymol using coordinates of crystal 
structures with the following PDB codes: 2FU5 (Mss4: Rab8), 2OT3 (Rabex-5: Rab21), 2COY (Sec4: Sec2) 
and 3CUE (TRAPP: Ypt1). 
 
 
5 Conclusions and Outlook 
In this thesis, full length and six C-terminal truncation variants of human Rab1A were 
produced to study the interaction with C-terminal domain of SidM (317-545). Each of 
them was screened over a wide variety of conditions to produce crystals in complex with 
SidM317-545 with the aim of solving the crystal structure of the complex. All truncation 
variants showed tight interaction with SidM317-545. However only the complex consisting of 
SidM317-545 and Rab1A1-175 and where both genes were co-expressed in E. coli was 
successfully crystallized. This implies that the C-terminus of Rab1A is flexible and hinders 
the crystallization of the complex. 
The interaction between two proteins were analysed by SEC, ITC and X-ray 
crystallography methods. The crystal structure of the SidM/Rab1A complex was solved, 
revealing that the GEF domain of SidM is structurally distinct from other known 
eukaryotic GEFs. The structure of the complex further revealed that SidM interacts mainly 
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with switch I, switch II and P-loop of Rab1A and induces conformational changes by 
dislocating switch I away from the nucleotide binding site and thereby disrupting Mg2+ and 
phosphate binding site releasing GDP from Rab1A. This is how SidM acts as an efficient 
GEF for Rab1A.  
Based on the structural information of the complex, SidM interacting residues Glu35, 
Tyr37 and Ile41 of switch I of Rab1A were substituted by alanine to assess the role of 
switch I in the binding affinity with SidM. ITC experiments have shown that these variants 
bind SidM with weaker affinity than wild type Rab1A. These results indicate that Switch I 
is critical for SidM binding.  On the other side, critical Rab1A interacting residues of SidM 
can also be targeted for mutational and structural analysis. Co-crystallizing these variants 
in complex and solving their crystal structures would give us detail insight on the mode of 
interaction between two proteins.  
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